https://www.medxy.ai/news/ja/probiotics-pregnancy-atopic-eczema 2026-03-05T22:20:34.000Z daily 0.75 https://www.medxy.ai/news/zh/probiotics-pregnancy-eczema 2026-03-05T22:20:23.000Z daily 0.75 https://www.medxy.ai/news/baricitinib-vs-azathioprine 2026-03-05T11:02:48.000Z daily 0.75 https://www.medxy.ai/news/vi/baricitinib-vs-azathioprine-3 2026-03-05T22:20:04.000Z daily 0.75 https://www.medxy.ai/news/ja/baricitinib-vs-azathioprine-atopic-dermatitis 2026-03-05T22:19:57.000Z daily 0.75 https://www.medxy.ai/news/bathing-frequency-eczema-severity 2026-03-05T22:19:49.000Z daily 0.75 https://www.medxy.ai/news/zh/baricitinib-vs-azathioprine-2 2026-03-05T22:11:36.000Z daily 0.75 https://www.medxy.ai/news/vi/bath-frequency-eczema-severity 2026-03-05T22:11:27.000Z daily 0.75 https://www.medxy.ai/news/ja/bathing-frequency-and-eczema-severity 2026-03-05T22:11:21.000Z daily 0.75 https://www.medxy.ai/news/zh/bath-frequency-eczema-severity-2 2026-03-05T22:11:12.000Z daily 0.75 https://www.medxy.ai/news/aletekitug-il18-dermatitis 2026-03-05T12:05:15.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-th2-aletekitug-il-18 2026-03-05T22:11:02.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-th2-atopic-dermatitis 2026-03-05T22:10:54.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-th2-il-18-targeting 2026-03-05T22:09:43.000Z daily 0.75 https://www.medxy.ai/news/apremilast-genital-psoriasis 2026-03-05T12:43:27.000Z daily 0.75 https://www.medxy.ai/news/vi/apremilast-genital-dermatitis 2026-03-05T22:09:28.000Z daily 0.75 https://www.medxy.ai/news/ja/apremilast-long-term-efficacy-safety 2026-03-05T22:09:22.000Z daily 0.75 https://www.medxy.ai/news/zh/aposter-long-term-effectiveness-safety 2026-03-05T22:09:08.000Z daily 0.75 https://www.medxy.ai/news/saturated-saline-immersion 2026-03-05T12:54:08.000Z daily 0.75 https://www.medxy.ai/news/eltrekibart-cxcr1-2-trial 2026-03-05T13:54:24.000Z daily 0.75 https://www.medxy.ai/news/vi/cxcr1-2-ligands-eltrekibart 2026-03-05T22:08:43.000Z daily 0.75 https://www.medxy.ai/news/ja/eltrekibart-cxcr1-2-trial-3 2026-03-05T22:08:38.000Z daily 0.75 https://www.medxy.ai/news/zh/eltrekibart-cxcr1-2-trial-2 2026-03-05T22:08:23.000Z daily 0.75 https://www.medxy.ai/news/precision-dosing-secukinumab 2026-03-05T22:08:12.000Z daily 0.75 https://www.medxy.ai/news/vi/secukinumab-dosing-hidradenitis-suppurativa 2026-03-05T22:08:05.000Z daily 0.75 https://www.medxy.ai/news/ja/secukinumab-dosing-insights 2026-03-05T22:08:00.000Z daily 0.75 https://www.medxy.ai/news/zh/sujindan-antibody-hidradenitis 2026-03-05T22:07:44.000Z daily 0.75 https://www.medxy.ai/news/high-dose-vilobelimab-hidradenitis-suppurativa 2026-03-05T14:45:27.000Z daily 0.75 https://www.medxy.ai/news/vi/high-dose-vilobelimab 2026-03-05T22:07:31.000Z daily 0.75 https://www.medxy.ai/news/ja/high-dose-vilobelimab-clinical-effect 2026-03-05T22:07:24.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-primary-endpoint-vilobelimab 2026-03-05T22:04:56.000Z daily 0.75 https://www.medxy.ai/news/pumecitinib-gel-efficacy 2026-03-05T19:39:31.000Z daily 0.75 https://www.medxy.ai/news/vi/gel-pumecitinib-3-efficacy 2026-03-05T22:04:28.000Z daily 0.75 https://www.medxy.ai/news/ja/pumace-tinib-gel-efficacy 2026-03-05T22:04:04.000Z daily 0.75 https://www.medxy.ai/news/zh/pumexetine-gel-efficacy 2026-03-05T22:03:46.000Z daily 0.75 https://www.medxy.ai/news/intermittent-chemotherapy-melanoma 2026-03-05T23:19:42.000Z daily 0.75 https://www.medxy.ai/news/vi/breaking-the-wall 2026-03-06T15:34:27.000Z daily 0.75 https://www.medxy.ai/news/ja/breaking-walls-chemotherapy-resistance 2026-03-06T15:34:37.000Z daily 0.75 https://www.medxy.ai/news/zh/breaking-barriers-intermittent-chemo-melanoma-resistance 2026-03-06T15:34:54.000Z daily 0.75 https://www.medxy.ai/news/bimekizumab-hidradenitis-suppurativa-2 2026-03-06T15:35:05.000Z daily 0.75 https://www.medxy.ai/news/vi/bimekizumab-hidradenitis-suppurativa 2026-03-06T15:36:15.000Z daily 0.75 https://www.medxy.ai/news/ja/bimekizumab-sweat-gland-inflammation 2026-03-06T15:36:22.000Z daily 0.75 https://www.medxy.ai/news/zh/bimekizumab-axillary-hidradenitis 2026-03-06T15:36:27.000Z daily 0.75 https://www.medxy.ai/news/targeted-tolerance-pemphigus 2026-03-06T15:36:34.000Z daily 0.75 https://www.medxy.ai/news/vi/pemphigus-vulgaris-nanocapsules 2026-03-06T15:36:38.000Z daily 0.75 https://www.medxy.ai/news/ja/targeted-tolerance-induction 2026-03-06T15:36:52.000Z daily 0.75 https://www.medxy.ai/news/zh/targeted-tolerance-induction-tpem203 2026-03-06T15:37:02.000Z daily 0.75 https://www.medxy.ai/news/botanical-solution-cinainu 2026-03-06T11:00:50.000Z daily 0.75 https://www.medxy.ai/news/vi/topical-cinainu-hair-loss 2026-03-06T15:37:13.000Z daily 0.75 https://www.medxy.ai/news/ja/local-plant-solution-test 2026-03-06T15:42:39.000Z daily 0.75 https://www.medxy.ai/news/zh/cinainu-efficacy-safety 2026-03-06T15:42:47.000Z daily 0.75 https://www.medxy.ai/news/sopoongsan-chronic-pruritus 2026-03-06T11:48:50.000Z daily 0.75 https://www.medxy.ai/news/vi/sopoongsan-stat1-inhibition 2026-03-06T15:42:55.000Z daily 0.75 https://www.medxy.ai/news/ja/soponsan-stat1-inhibition-itch-relief 2026-03-06T15:44:58.000Z daily 0.75 https://www.medxy.ai/news/zh/songfeng-disperses-chronic-itch 2026-03-06T15:45:04.000Z daily 0.75 https://www.medxy.ai/news/orforglipron-vs-semaglutide 2026-03-06T12:56:18.000Z daily 0.75 https://www.medxy.ai/news/vi/orforglipron-vs-semaglutide-hba1c 2026-03-06T15:45:15.000Z daily 0.75 https://www.medxy.ai/news/ja/orforglipron-vs-semaglutide-2 2026-03-06T15:45:21.000Z daily 0.75 https://www.medxy.ai/news/questioning-hormone-therapy 2026-03-06T13:02:33.000Z daily 0.75 https://www.medxy.ai/news/zh/orforglipron-vs-semaglutide-3 2026-03-06T15:45:29.000Z daily 0.75 https://www.medxy.ai/news/vi/hormone-therapy-prostate-cancer 2026-03-06T15:45:47.000Z daily 0.75 https://www.medxy.ai/news/ja/routine-hormone-therapy-review 2026-03-06T15:46:08.000Z daily 0.75 https://www.medxy.ai/news/zh/questioning-hormone-therapy-2 2026-03-06T15:46:21.000Z daily 0.75 https://www.medxy.ai/news/beyond-dopamine-blocking 2026-03-06T13:10:12.000Z daily 0.75 https://www.medxy.ai/news/comparative-efficacy-antipsychotics 2026-03-06T13:14:33.000Z daily 0.75 https://www.medxy.ai/news/vi/muscarinic-interventions-analysis 2026-03-06T15:46:45.000Z daily 0.75 https://www.medxy.ai/news/ja/antipsychotic-comparison-analysis 2026-03-06T13:19:28.000Z daily 0.75 https://www.medxy.ai/news/zh/antipsychotic-comparison-analysis 2026-03-06T13:21:37.000Z daily 0.75 https://www.medxy.ai/news/cellular-therapy-myelo-repair 2026-03-06T13:24:37.000Z daily 0.75 https://www.medxy.ai/news/patient-centered-outcomes-geriatrics 2026-03-06T15:46:59.000Z daily 0.75 https://www.medxy.ai/news/vi/geriatric-cancer-patient-outcomes 2026-03-06T15:47:04.000Z daily 0.75 https://www.medxy.ai/news/ja/patient-outcomes-elderly-oncology 2026-03-06T15:47:10.000Z daily 0.75 https://www.medxy.ai/news/zh/patient-centered-outcomes 2026-03-06T15:47:15.000Z daily 0.75 https://www.medxy.ai/news/genomic-therapy-rare-cancers 2026-03-06T15:47:23.000Z daily 0.75 https://www.medxy.ai/news/vi/gen-therapy-in-rare-cancers 2026-03-06T15:47:27.000Z daily 0.75 https://www.medxy.ai/news/ja/genome-therapy-matching 2026-03-06T15:47:38.000Z daily 0.75 https://www.medxy.ai/news/zh/genomic-therapy-matching 2026-03-06T15:47:43.000Z daily 0.75 https://www.medxy.ai/news/pharmacotherapy-hypertrophic-cardiomyopathy 2026-03-06T15:47:54.000Z daily 0.75 https://www.medxy.ai/news/vi/drug-therapy-review-hcm 2026-03-06T15:47:58.000Z daily 0.75 https://www.medxy.ai/news/ja/reconsidering-drug-therapy-hypertrophic-cardiomyopathy 2026-03-06T15:48:24.000Z daily 0.75 https://www.medxy.ai/news/zh/revisiting-hypertrophic-cardiomyopathy-treatment 2026-03-06T15:48:29.000Z daily 0.75 https://www.medxy.ai/news/silent-genetic-threat 2026-03-06T15:13:41.000Z daily 0.75 https://www.medxy.ai/news/vi/silent-genetic-threat-2 2026-03-06T15:48:35.000Z daily 0.75 https://www.medxy.ai/news/ja/silent-genetic-threat-3 2026-03-06T15:48:43.000Z daily 0.75 https://www.medxy.ai/news/zh/silent-genetic-threat-4 2026-03-06T15:48:49.000Z daily 0.75 https://www.medxy.ai/news/mutton-hf-indigenous-foods 2026-03-06T15:58:25.000Z daily 0.75 https://www.medxy.ai/news/vi/mutton-hf-food-system-recovery 2026-03-06T15:48:57.000Z daily 0.75 https://www.medxy.ai/news/ja/mutton-hf-indigenous-food-systems-2 2026-03-06T15:49:05.000Z daily 0.75 https://www.medxy.ai/news/zh/mutton-hf-indigenous-food-systems 2026-03-06T15:49:10.000Z daily 0.75 https://www.medxy.ai/news/precision-risk-stratification 2026-03-06T15:58:21.000Z daily 0.75 https://www.medxy.ai/news/vi/cushing-risk-classification 2026-03-06T15:58:00.000Z daily 0.75 https://www.medxy.ai/news/ja/cushing-disease-risk-stratification-2 2026-03-06T15:58:11.000Z daily 0.75 https://www.medxy.ai/news/zh/cushing-disease-risk-stratification 2026-03-06T15:58:17.000Z daily 0.75 https://www.medxy.ai/news/sglt2-inhibitors-gout-relief 2026-03-06T15:57:48.000Z daily 0.75 https://www.medxy.ai/news/vi/sglt2-inhibitor-gout-treatment 2026-03-06T16:31:52.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-inhibitors-gout-relief-2 2026-03-06T16:31:39.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-inhibitors-gout-burden 2026-03-06T16:31:22.000Z daily 0.75 https://www.medxy.ai/news/oxygen-guided-success 2026-03-06T16:09:07.000Z daily 0.75 https://www.medxy.ai/news/mody-diagnosis-novel-variants 2026-03-06T16:20:22.000Z daily 0.75 https://www.medxy.ai/news/vi/mody-diagnosis-ins-variants 2026-03-06T16:30:44.000Z daily 0.75 https://www.medxy.ai/news/ja/mody-diagnosis-redefined 2026-03-06T16:30:53.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-dosage-deficiency 2026-03-06T16:31:06.000Z daily 0.75 https://www.medxy.ai/news/active-surveillance-thyroid-nodules 2026-03-06T16:30:18.000Z daily 0.75 https://www.medxy.ai/news/vi/active-safety-ras-tumors 2026-03-06T23:03:16.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-surgical-removal 2026-03-06T23:03:01.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-surgical-removal-2 2026-03-06T23:02:48.000Z daily 0.75 https://www.medxy.ai/news/antiepileptogenesis-stroke-eslicarbazepine 2026-03-06T16:40:01.000Z daily 0.75 https://www.medxy.ai/news/vi/stroke-seizure-prevention 2026-03-06T23:02:36.000Z daily 0.75 https://www.medxy.ai/news/ja/stroke-treatment-evaluation 2026-03-06T23:02:29.000Z daily 0.75 https://www.medxy.ai/news/zh/stroke-epilepsy-prevention 2026-03-06T23:02:24.000Z daily 0.75 https://www.medxy.ai/news/rethinking-rhythm-control 2026-03-06T23:02:19.000Z daily 0.75 https://www.medxy.ai/news/vi/heart-rate-control-stroke-prevention 2026-03-06T23:02:12.000Z daily 0.75 https://www.medxy.ai/news/ja/rhythm-control-stroke-prevention 2026-03-06T23:02:08.000Z daily 0.75 https://www.medxy.ai/news/zh/rethinking-heart-rate-control 2026-03-06T23:02:03.000Z daily 0.75 https://www.medxy.ai/news/age-onset-nmosd 2026-03-06T23:01:52.000Z daily 0.75 https://www.medxy.ai/news/vi/age-onset-nmosd-2 2026-03-06T23:01:46.000Z daily 0.75 https://www.medxy.ai/news/ja/aqp4-igg-nmosd-age-clinical-course 2026-03-06T23:01:39.000Z daily 0.75 https://www.medxy.ai/news/zh/aqp4-igg-nmosd-onset-age 2026-03-06T23:01:34.000Z daily 0.75 https://www.medxy.ai/news/genetic-breakthrough-snubn-variants 2026-03-06T23:01:10.000Z daily 0.75 https://www.medxy.ai/news/watchful-waiting-anxiety 2026-03-06T23:01:04.000Z daily 0.75 https://www.medxy.ai/news/vi/psychological-burden-aneurysm-risk 2026-03-06T23:01:02.000Z daily 0.75 https://www.medxy.ai/news/ja/waiting-observation-mental-burden 2026-03-06T23:00:49.000Z daily 0.75 https://www.medxy.ai/news/zh/psychological-burden-observation 2026-03-06T23:00:42.000Z daily 0.75 https://www.medxy.ai/news/stem-cell-therapy-misfire 2026-03-06T23:03:26.000Z daily 0.75 https://www.medxy.ai/news/vi/stem-cell-therapy-failed 2026-03-07T12:00:25.000Z daily 0.75 https://www.medxy.ai/news/ja/stem-cell-therapy-failure 2026-03-07T12:00:43.000Z daily 0.75 https://www.medxy.ai/news/zh/stem-cell-therapy-fistula 2026-03-07T12:00:53.000Z daily 0.75 https://www.medxy.ai/news/goulash-trial-nutrition 2026-03-07T07:12:33.000Z daily 0.75 https://www.medxy.ai/news/vi/not-more-is-better-3 2026-03-07T12:01:35.000Z daily 0.75 https://www.medxy.ai/news/ja/not-more-is-better-4 2026-03-07T12:01:47.000Z daily 0.75 https://www.medxy.ai/news/zh/not-more-is-better-5 2026-03-07T12:01:54.000Z daily 0.75 https://www.medxy.ai/news/optimizing-immunotherapy-cholangiocarcinoma 2026-03-07T12:02:11.000Z daily 0.75 https://www.medxy.ai/news/vi/optimal-immunotherapy-bile-duct-cancer 2026-03-07T12:02:21.000Z daily 0.75 https://www.medxy.ai/news/zh/catalyzing-immunotherapy-in-cholangiocarcinoma 2026-03-07T12:02:38.000Z daily 0.75 https://www.medxy.ai/news/imatinib-kits-exon-9-gist-2 2026-03-07T12:02:43.000Z daily 0.75 https://www.medxy.ai/news/vi/imatinib-kits-exon-9-gist 2026-03-07T12:02:54.000Z daily 0.75 https://www.medxy.ai/news/ja/imatinib-gist-survival-evidence 2026-03-07T12:03:03.000Z daily 0.75 https://www.medxy.ai/news/zh/imatinib-survival-study-gist 2026-03-07T12:03:17.000Z daily 0.75 https://www.medxy.ai/news/scar-evolution-mri-outcomes 2026-03-07T12:03:06.000Z daily 0.75 https://www.medxy.ai/news/beyond-traditional-risk-factors 2026-03-07T12:05:42.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-traditional-risk-factors 2026-03-07T12:08:22.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-traditional-risk-factors 2026-03-07T12:10:31.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-traditional-risk-factors 2026-03-07T12:12:24.000Z daily 0.75 https://www.medxy.ai/news/preventive-pci-vulnerable-plaques 2026-03-07T13:19:17.000Z daily 0.75 https://www.medxy.ai/news/vi/pci-for-unrestricted-atherosclerosis 2026-03-07T13:23:11.000Z daily 0.75 https://www.medxy.ai/news/ja/non-flow-limiting-plaques-pci 2026-03-07T13:25:14.000Z daily 0.75 https://www.medxy.ai/news/zh/preventive-pci-non-flow-limiting 2026-03-07T13:27:20.000Z daily 0.75 https://www.medxy.ai/news/beyond-binary-aldosteronism 2026-03-07T14:07:54.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-binary-aldosteronism-risk 2026-03-07T14:09:49.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-binary-aldosterone-risk 2026-03-07T14:12:02.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-binarity-aldosterone-risk 2026-03-07T14:14:48.000Z daily 0.75 https://www.medxy.ai/news/prevalence-restriction-systolic-dysfunction 2026-03-07T17:28:20.000Z daily 0.75 https://www.medxy.ai/news/synergistic-protection-glp1-lifestyle 2026-03-07T17:29:35.000Z daily 0.75 https://www.medxy.ai/news/vi/protecting-health-glp-1 2026-03-07T17:33:21.000Z daily 0.75 https://www.medxy.ai/news/ja/coordinated-protection-glp-1 2026-03-07T17:35:10.000Z daily 0.75 https://www.medxy.ai/news/zh/collaborative-protection-glp1 2026-03-07T17:37:26.000Z daily 0.75 https://www.medxy.ai/news/renal-function-dka-risk 2026-03-07T17:38:51.000Z daily 0.75 https://www.medxy.ai/news/vi/renal-function-risk-dka 2026-03-07T17:43:28.000Z daily 0.75 https://www.medxy.ai/news/ja/kidney-function-metabolism-risk 2026-03-07T17:45:18.000Z daily 0.75 https://www.medxy.ai/news/zh/kidney-function-metabolic-risk 2026-03-07T17:46:46.000Z daily 0.75 https://www.medxy.ai/news/24-vs-12-week-triptorelin 2026-03-07T19:15:31.000Z daily 0.75 https://www.medxy.ai/news/vi/triptorelin-24-vs-12-weeks 2026-03-07T19:17:57.000Z daily 0.75 https://www.medxy.ai/news/ja/triptoledin-dosing-comparison 2026-03-07T19:20:53.000Z daily 0.75 https://www.medxy.ai/news/zh/24-12-week-triporelin 2026-03-07T19:23:10.000Z daily 0.75 https://www.medxy.ai/news/deciphering-znt8a-autoantibodies 2026-03-07T19:00:34.000Z daily 0.75 https://www.medxy.ai/news/vi/decode-znt8a-diabetes-risk 2026-03-07T19:03:16.000Z daily 0.75 https://www.medxy.ai/news/ja/znt8a-and-type-1-diabetes 2026-03-07T19:05:47.000Z daily 0.75 https://www.medxy.ai/news/zh/znt8a-insulin-antibodies 2026-03-07T19:08:08.000Z daily 0.75 https://www.medxy.ai/news/thyroid-ultrasound-risk-stratification 2026-03-08T08:40:09.000Z daily 0.75 https://www.medxy.ai/news/vi/ultrasound-risk-classification 2026-03-08T08:43:03.000Z daily 0.75 https://www.medxy.ai/news/ja/thyroid-ultrasound-risk-assessment 2026-03-08T08:44:49.000Z daily 0.75 https://www.medxy.ai/news/zh/global-thyroid-ultrasound-risk-assessment 2026-03-08T08:45:43.000Z daily 0.75 https://www.medxy.ai/news/fordadistrogene-fails-duchenne-trial 2026-03-08T09:19:08.000Z daily 0.75 https://www.medxy.ai/news/vi/fordadistrogene-movaparvovec-duchenne 2026-03-08T11:25:16.000Z daily 0.75 https://www.medxy.ai/news/ja/duchenne-muscular-dystrophy-outcomes 2026-03-08T11:25:10.000Z daily 0.75 https://www.medxy.ai/news/zh/fordadistrogene-movaparvovec-dupuytrens-disease 2026-03-08T11:25:03.000Z daily 0.75 https://www.medxy.ai/news/low-dose-lithium-cognitive-impairment-2 2026-03-08T11:24:44.000Z daily 0.75 https://www.medxy.ai/news/vi/low-dose-lithium-cognitive-disorder 2026-03-08T11:24:53.000Z daily 0.75 https://www.medxy.ai/news/genomic-landscape-ms 2026-03-08T11:24:35.000Z daily 0.75 https://www.medxy.ai/news/zh/low-dose-lithium-cognitive-disorder-2 2026-03-08T11:24:24.000Z daily 0.75 https://www.medxy.ai/news/vi/ms-research-landscape-mapping 2026-03-08T11:24:07.000Z daily 0.75 https://www.medxy.ai/news/ja/ms-genome-map-insights 2026-03-08T11:23:57.000Z daily 0.75 https://www.medxy.ai/news/zh/multiple-sclerosis-genetics 2026-03-08T11:23:44.000Z daily 0.75 https://www.medxy.ai/news/scrotal-health-guide 2026-03-08T11:05:22.000Z daily 0.75 https://www.medxy.ai/news/vi/testicle-health-guide 2026-03-08T11:23:26.000Z daily 0.75 https://www.medxy.ai/news/ja/scrotum-health-guide 2026-03-08T11:23:19.000Z daily 0.75 https://www.medxy.ai/news/treatment-evolution-5q-sma 2026-03-08T11:23:02.000Z daily 0.75 https://www.medxy.ai/news/vi/treatment-process-atrophia-5q 2026-03-08T19:13:46.000Z daily 0.75 https://www.medxy.ai/news/ja/5q-sma-treatment-evolution-2 2026-03-08T19:13:51.000Z daily 0.75 https://www.medxy.ai/news/zh/5q-sma-treatment-evolution 2026-03-08T19:13:57.000Z daily 0.75 https://www.medxy.ai/news/minimally-invasive-endoscopic-techniques 2026-03-08T11:19:38.000Z daily 0.75 https://www.medxy.ai/news/vi/minimally-invasive-endoscopy 2026-03-08T19:14:07.000Z daily 0.75 https://www.medxy.ai/news/ja/minimally-invasive-neuroplex-recovery 2026-03-08T19:14:22.000Z daily 0.75 https://www.medxy.ai/news/zh/endoscopic-nerve-management 2026-03-08T19:14:34.000Z daily 0.75 https://www.medxy.ai/news/therapeutic-blood-derivatives 2026-03-08T19:14:47.000Z daily 0.75 https://www.medxy.ai/news/vi/potential-blood-products-therapy 2026-03-08T19:14:53.000Z daily 0.75 https://www.medxy.ai/news/ja/self-derived-blood-therapy 2026-03-08T19:14:57.000Z daily 0.75 https://www.medxy.ai/news/zh/autologous-blood-derivatives-research 2026-03-08T19:15:03.000Z daily 0.75 https://www.medxy.ai/news/differential-pathophysiology-angiopathy 2026-03-08T19:15:18.000Z daily 0.75 https://www.medxy.ai/news/vi/disease-role-vascular-space 2026-03-08T19:15:24.000Z daily 0.75 https://www.medxy.ai/news/ja/cerebral-vasculopathy-biomarkers 2026-03-08T19:15:30.000Z daily 0.75 https://www.medxy.ai/news/zh/half-oval-perivascular-spaces 2026-03-08T19:15:34.000Z daily 0.75 https://www.medxy.ai/news/tryptophan-tug-of-war 2026-03-08T15:27:30.000Z daily 0.75 https://www.medxy.ai/news/vi/tryptophan-war-colon-cancer 2026-03-08T19:15:43.000Z daily 0.75 https://www.medxy.ai/news/ja/tryptophan-interaction-colon-cancer 2026-03-08T19:15:51.000Z daily 0.75 https://www.medxy.ai/news/zh/tryptophan-battle-colon-cancer 2026-03-08T19:16:01.000Z daily 0.75 https://www.medxy.ai/news/bemnifosbuvir-hepatitis-e-inhibition 2026-03-08T19:16:11.000Z daily 0.75 https://www.medxy.ai/news/vi/bemnifosbuvir-hepatitis-e-2 2026-03-08T19:16:14.000Z daily 0.75 https://www.medxy.ai/news/ja/bemnifosbuvir-hepatitis-e 2026-03-08T19:16:28.000Z daily 0.75 https://www.medxy.ai/news/zh/beninaprevir-hcv-suppression 2026-03-08T19:16:37.000Z daily 0.75 https://www.medxy.ai/news/unmasking-dars1 2026-03-08T17:10:45.000Z daily 0.75 https://www.medxy.ai/news/vi/dars1-in-liver-cancer 2026-03-08T19:16:47.000Z daily 0.75 https://www.medxy.ai/news/ja/dars1-masks-revealed 2026-03-08T19:16:53.000Z daily 0.75 https://www.medxy.ai/news/zh/dars1-saga-myc-mechanism 2026-03-08T19:17:02.000Z daily 0.75 https://www.medxy.ai/news/long-term-tislelizumab-survival 2026-03-09T10:43:57.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-survival-tislelizumab 2026-03-09T15:41:25.000Z daily 0.75 https://www.medxy.ai/news/ja/tislelizumab-long-term-survival 2026-03-09T15:41:11.000Z daily 0.75 https://www.medxy.ai/news/zh/treatment-benefits-nasopharyngeal-cancer 2026-03-09T15:41:01.000Z daily 0.75 https://www.medxy.ai/news/genotype-phenotype-divergence 2026-03-09T15:40:47.000Z daily 0.75 https://www.medxy.ai/news/vi/genetic-phenotypic-divergence 2026-03-09T15:40:38.000Z daily 0.75 https://www.medxy.ai/news/ja/hypertrophic-cardiomyopathy-genotype-phenotype 2026-03-09T15:40:32.000Z daily 0.75 https://www.medxy.ai/news/zh/hypertrophic-cardiomyopathy-genotype-phenotype-2 2026-03-09T15:40:27.000Z daily 0.75 https://www.medxy.ai/news/long-term-intravascular-imaging-results 2026-03-09T15:40:22.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-optimization-intracardiac-images 2026-03-09T15:40:17.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-advantages-vascular-imaging 2026-03-09T15:40:06.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-benefits-vascular-imaging 2026-03-09T15:39:54.000Z daily 0.75 https://www.medxy.ai/news/inhibiting-myelid-plexind1-atherosclerosis 2026-03-09T11:13:24.000Z daily 0.75 https://www.medxy.ai/news/vi/myeloid-plexind1-strategy 2026-03-09T15:39:46.000Z daily 0.75 https://www.medxy.ai/news/ja/bone-marrow-cells-inhibition 2026-03-09T15:39:27.000Z daily 0.75 https://www.medxy.ai/news/zh/suppress-plexind1-atherosclerosis-strategy 2026-03-09T15:39:21.000Z daily 0.75 https://www.medxy.ai/news/long-term-pfo-closure-study 2026-03-09T11:39:39.000Z daily 0.75 https://www.medxy.ai/news/precision-prediction-heart-failure 2026-03-09T15:39:13.000Z daily 0.75 https://www.medxy.ai/news/vi/accurate-prediction-heart-failure-ai 2026-03-09T15:39:06.000Z daily 0.75 https://www.medxy.ai/news/ja/heart-failure-prediction-ai-ecg 2026-03-09T15:39:00.000Z daily 0.75 https://www.medxy.ai/news/zh/precise-heart-failure-ai 2026-03-09T15:38:54.000Z daily 0.75 https://www.medxy.ai/news/tubeless-insulin-delivery 2026-03-09T15:38:48.000Z daily 0.75 https://www.medxy.ai/news/vi/insulin-delivery-system-insights 2026-03-09T15:38:42.000Z daily 0.75 https://www.medxy.ai/news/ja/tubeless-insulin-delivery-2 2026-03-09T15:38:36.000Z daily 0.75 https://www.medxy.ai/news/zh/transition-to-insulin-pump 2026-03-09T15:38:30.000Z daily 0.75 https://www.medxy.ai/news/testosterone-weight-loss 2026-03-09T15:38:24.000Z daily 0.75 https://www.medxy.ai/news/vi/testosterone-weight-loss-4 2026-03-09T15:38:16.000Z daily 0.75 https://www.medxy.ai/news/ja/testosterone-weight-loss-3 2026-03-09T15:38:02.000Z daily 0.75 https://www.medxy.ai/news/graves-disease-pregnancy-management 2026-03-09T15:36:41.000Z daily 0.75 https://www.medxy.ai/news/zh/testosterone-weight-loss-2 2026-03-09T15:37:02.000Z daily 0.75 https://www.medxy.ai/news/vi/graves-disease-pregnancy 2026-03-09T15:37:15.000Z daily 0.75 https://www.medxy.ai/news/ja/graves-disease-management-pregnancy 2026-03-09T15:37:27.000Z daily 0.75 https://www.medxy.ai/news/zh/graves-disease-management 2026-03-09T15:37:40.000Z daily 0.75 https://www.medxy.ai/news/hiit-mitochondrial-remodeling 2026-03-09T15:14:43.000Z daily 0.75 https://www.medxy.ai/news/vi/high-intensity-training-mitochondria 2026-03-09T15:41:48.000Z daily 0.75 https://www.medxy.ai/news/ja/high-intensity-interval-training-mitochondria-repair 2026-03-09T15:41:57.000Z daily 0.75 https://www.medxy.ai/news/zh/high-intensity-interval-training-mitochondrial-structure 2026-03-09T15:42:03.000Z daily 0.75 https://www.medxy.ai/news/targeted-postoperative-exercises 2026-03-09T15:23:16.000Z daily 0.75 https://www.medxy.ai/news/vi/post-surgery-care-exercises 2026-03-09T15:42:15.000Z daily 0.75 https://www.medxy.ai/news/ja/thyroid-surgery-exercise-benefits 2026-03-09T15:42:24.000Z daily 0.75 https://www.medxy.ai/news/zh/targeted-postoperative-exercise 2026-03-09T15:42:32.000Z daily 0.75 https://www.medxy.ai/news/challenging-more-is-better 2026-03-09T15:31:32.000Z daily 0.75 https://www.medxy.ai/news/vi/challenge-best-is-more 2026-03-09T15:42:42.000Z daily 0.75 https://www.medxy.ai/news/ja/challenge-to-more-is-better 2026-03-09T15:42:58.000Z daily 0.75 https://www.medxy.ai/news/zh/challenging-more-is-better-2 2026-03-09T15:43:11.000Z daily 0.75 https://www.medxy.ai/news/precision-rehabilitation-stroke 2026-03-10T10:04:22.000Z daily 0.75 https://www.medxy.ai/news/vi/accurate-recovery-stroke 2026-03-10T10:04:27.000Z daily 0.75 https://www.medxy.ai/news/ja/chronic-stroke-rehabilitation-2 2026-03-10T10:04:32.000Z daily 0.75 https://www.medxy.ai/news/zh/chronic-stroke-rehab 2026-03-10T10:04:40.000Z daily 0.75 https://www.medxy.ai/news/dual-pathology-burden 2026-03-09T15:54:30.000Z daily 0.75 https://www.medxy.ai/news/vi/alzheimer-ftld-comorbidity 2026-03-10T10:04:52.000Z daily 0.75 https://www.medxy.ai/news/ja/dual-pathology-alzheimers-frontotemporal-degeneration 2026-03-10T10:04:57.000Z daily 0.75 https://www.medxy.ai/news/zh/dual-pathology-burden-2 2026-03-10T10:05:05.000Z daily 0.75 https://www.medxy.ai/news/mild-bleeding-risk 2026-03-09T16:04:27.000Z daily 0.75 https://www.medxy.ai/news/vi/light-bleeding-risk-analysis 2026-03-10T10:05:13.000Z daily 0.75 https://www.medxy.ai/news/ja/mild-bleeding-significance 2026-03-10T10:05:23.000Z daily 0.75 https://www.medxy.ai/news/zh/slight-bleeding-risk 2026-03-10T10:05:44.000Z daily 0.75 https://www.medxy.ai/news/new-consensus-apc-mosaicism 2026-03-09T16:11:01.000Z daily 0.75 https://www.medxy.ai/news/zh/apc-phenomenon-consensus 2026-03-10T10:05:52.000Z daily 0.75 https://www.medxy.ai/news/vi/apc-mosaicism-agreement 2026-03-10T10:05:59.000Z daily 0.75 https://www.medxy.ai/news/autoimmune-gastritis-diversity 2026-03-09T16:16:58.000Z daily 0.75 https://www.medxy.ai/news/ja/apc-mosaic-consensus 2026-03-10T10:06:14.000Z daily 0.75 https://www.medxy.ai/news/vi/global-diversity-autoimmune-gastritis 2026-03-10T10:06:24.000Z daily 0.75 https://www.medxy.ai/news/ja/autoimmune-gastritis-diversity-2 2026-03-10T10:06:29.000Z daily 0.75 https://www.medxy.ai/news/zh/autoimmune-gastritis-diversity-3 2026-03-10T10:06:34.000Z daily 0.75 https://www.medxy.ai/news/cure-for-follicular-lymphoma 2026-03-10T10:06:42.000Z daily 0.75 https://www.medxy.ai/news/vi/uncurable-lymphoma-challenge 2026-03-10T10:06:48.000Z daily 0.75 https://www.medxy.ai/news/ja/challenging-incurable-concept 2026-03-10T10:06:58.000Z daily 0.75 https://www.medxy.ai/news/zh/challenging-untreatable-paradigm 2026-03-10T10:07:02.000Z daily 0.75 https://www.medxy.ai/news/ross-procedure-survival 2026-03-09T16:42:23.000Z daily 0.75 https://www.medxy.ai/news/vi/ross-technique-recovery 2026-03-10T10:07:11.000Z daily 0.75 https://www.medxy.ai/news/ja/surgical-revival-survival-factors 2026-03-10T10:07:23.000Z daily 0.75 https://www.medxy.ai/news/zh/roses-surgery-revival 2026-03-10T10:07:32.000Z daily 0.75 https://www.medxy.ai/news/taurochenodeoxycholic-acid-obesity-endothelial-dysfunction 2026-03-09T18:01:21.000Z daily 0.75 https://www.medxy.ai/news/vi/taurochenodeoxycholic-acid 2026-03-10T10:07:37.000Z daily 0.75 https://www.medxy.ai/news/ja/taurohynodeoxycholic-acid 2026-03-10T10:07:45.000Z daily 0.75 https://www.medxy.ai/news/low-dose-rivaroxaban-thrombosis-prevention 2026-03-09T18:07:32.000Z daily 0.75 https://www.medxy.ai/news/zh/tauroursodeoxycholic-acid-endothelial-function 2026-03-10T10:07:51.000Z daily 0.75 https://www.medxy.ai/news/beyond-gradient-aortic-stenosis 2026-03-09T18:10:31.000Z daily 0.75 https://www.medxy.ai/news/vi/hemodynamics-exercise-gradient-disorder 2026-03-10T10:07:57.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-slope-affirming-high-risk-aortic-stenosis 2026-03-10T10:08:02.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-gradient-aortic-stenosis-2 2026-03-10T10:08:16.000Z daily 0.75 https://www.medxy.ai/news/romosozumab-review 2026-03-10T10:08:47.000Z daily 0.75 https://www.medxy.ai/news/vi/romosozumab-therapy-osteoporosis 2026-03-10T10:08:57.000Z daily 0.75 https://www.medxy.ai/news/ja/romosozumab-shortened-schedule 2026-03-10T10:09:10.000Z daily 0.75 https://www.medxy.ai/news/zh/romosozumab-treatment-revision 2026-03-10T10:09:17.000Z daily 0.75 https://www.medxy.ai/news/cardiac-myofibroblasts-pah 2026-03-09T22:07:45.000Z daily 0.75 https://www.medxy.ai/news/vi/myofibroblasts-and-ucp2-in-pah 2026-03-10T10:09:24.000Z daily 0.75 https://www.medxy.ai/news/ja/compensation-to-collapse 2026-03-10T10:09:33.000Z daily 0.75 https://www.medxy.ai/news/zh/right-ventricle-fate-pulmonary-hypertension 2026-03-10T10:09:44.000Z daily 0.75 https://www.medxy.ai/news/varenicline-ventricular-ectopy 2026-03-09T22:18:58.000Z daily 0.75 https://www.medxy.ai/news/semaglutide-vascular-regeneration 2026-03-09T22:21:34.000Z daily 0.75 https://www.medxy.ai/news/vi/semaglutide-blood-vessel-regeneration 2026-03-10T10:09:52.000Z daily 0.75 https://www.medxy.ai/news/ja/semaglutide-vasculogenesis 2026-03-10T10:10:04.000Z daily 0.75 https://www.medxy.ai/news/zh/semaglutide-vascular-regeneration-2 2026-03-10T10:10:10.000Z daily 0.75 https://www.medxy.ai/news/gnrh-antagonists-heart-benefits 2026-03-09T22:36:27.000Z daily 0.75 https://www.medxy.ai/news/vi/gnrh-antagonists-heart-health 2026-03-10T10:10:17.000Z daily 0.75 https://www.medxy.ai/news/ja/gnrh-antagonists-cardiac-protection 2026-03-10T10:10:24.000Z daily 0.75 https://www.medxy.ai/news/zh/gnrh-antagonists-heart-protection 2026-03-10T10:10:32.000Z daily 0.75 https://www.medxy.ai/news/cardiogenic-shock-management 2026-03-10T10:01:53.000Z daily 0.75 https://www.medxy.ai/news/anabolic-therapy-comparison 2026-03-10T10:10:45.000Z daily 0.75 https://www.medxy.ai/news/vi/optimize-anabolic-therapy 2026-03-10T10:10:52.000Z daily 0.75 https://www.medxy.ai/news/ja/optimization-anabolic-therapy 2026-03-10T10:11:52.000Z daily 0.75 https://www.medxy.ai/news/zh/optimizing-therapy-comparison 2026-03-10T10:12:06.000Z daily 0.75 https://www.medxy.ai/news/early-antennatal-prediabetes-danger 2026-03-10T10:11:07.000Z daily 0.75 https://www.medxy.ai/news/vi/early-diabetes-detection-pregnancy 2026-03-10T11:00:54.000Z daily 0.75 https://www.medxy.ai/news/zh/early-pregnancy-pre-diabetes 2026-03-10T11:01:05.000Z daily 0.75 https://www.medxy.ai/news/elevated-mcp1-fabp4-early-pcos 2026-03-10T10:24:05.000Z daily 0.75 https://www.medxy.ai/news/vi/mcp1-fabp4-levels-pcos 2026-03-10T11:01:14.000Z daily 0.75 https://www.medxy.ai/news/zh/mcp1-fabp4-elevation 2026-03-10T11:01:27.000Z daily 0.75 https://www.medxy.ai/news/trans-ancestry-diabetes-risk 2026-03-10T10:47:52.000Z daily 0.75 https://www.medxy.ai/news/vi/can-bang-san-choi-diem-nguy-co-moi 2026-03-10T11:01:39.000Z daily 0.75 https://www.medxy.ai/news/ja/fairness-in-competition 2026-03-10T11:01:47.000Z daily 0.75 https://www.medxy.ai/news/beyond-thyroglobulin-thyroid-hormone 2026-03-10T10:54:03.000Z daily 0.75 https://www.medxy.ai/news/zh/balanced-competition-environment 2026-03-10T11:01:54.000Z daily 0.75 https://www.medxy.ai/news/precision-diagnostics-alzheimers 2026-03-10T11:02:02.000Z daily 0.75 https://www.medxy.ai/news/vi/accurate-diagnosis-alzheimer 2026-03-10T11:02:08.000Z daily 0.75 https://www.medxy.ai/news/ja/alzheimer-precision-diagnosis 2026-03-10T15:16:01.000Z daily 0.75 https://www.medxy.ai/news/zh/alzheimers-diagnosis-p-tau217 2026-03-10T15:16:07.000Z daily 0.75 https://www.medxy.ai/news/hip-strength-gait-speed 2026-03-10T11:10:47.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-the-surface-hip-strength 2026-03-10T15:16:12.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-the-surface-why-thigh-strength-and-walking-speed-are-new-gold-standards-for-monitoring-late-onset-pompe-disease 2026-03-10T15:16:18.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-the-surface 2026-03-10T15:18:33.000Z daily 0.75 https://www.medxy.ai/news/blood-brain-barrier-biomarker 2026-03-10T12:08:42.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-blood-brain-barrier 2026-03-10T15:18:43.000Z daily 0.75 https://www.medxy.ai/news/ja/blood-brain-barrier-tspo-ms-biomarker 2026-03-10T15:18:53.000Z daily 0.75 https://www.medxy.ai/news/zh/blood-brain-barrier-tspo 2026-03-10T15:19:02.000Z daily 0.75 https://www.medxy.ai/news/perihematomal-edema-outcomes 2026-03-10T15:19:10.000Z daily 0.75 https://www.medxy.ai/news/vi/edema-kinematics-and-functional-outcomes-in-spontaneous-hemorrhage 2026-03-10T12:20:54.000Z daily 0.75 https://www.medxy.ai/news/ja/spontaneous-hemorrhage-outcomes 2026-03-10T15:19:20.000Z daily 0.75 https://www.medxy.ai/news/zh/intracerebral-hemorrhage-outcomes 2026-03-10T15:19:27.000Z daily 0.75 https://www.medxy.ai/news/beyond-clinical-remission 2026-03-10T12:35:17.000Z daily 0.75 https://www.medxy.ai/news/vi/after-clinical-recovery-crohns 2026-03-10T15:19:32.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-clinical-remission-2 2026-03-10T15:19:37.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-clinical-remission-3 2026-03-10T15:19:43.000Z daily 0.75 https://www.medxy.ai/news/hepatocyte-cebpa-orm1-axis 2026-03-10T15:19:50.000Z daily 0.75 https://www.medxy.ai/news/vi/cebp-orm1-liver-pathway 2026-03-10T15:19:55.000Z daily 0.75 https://www.medxy.ai/news/ja/cebp-orm1-axis-alcohol-liver-disease-2 2026-03-10T15:20:03.000Z daily 0.75 https://www.medxy.ai/news/zh/cebp-orm1-axis-alcohol-liver-disease 2026-03-10T15:20:09.000Z daily 0.75 https://www.medxy.ai/news/intramuscular-fat-muscle-dysfunction 2026-03-10T15:20:15.000Z daily 0.75 https://www.medxy.ai/news/vi/muscle-fat-accumulation-2 2026-03-10T15:20:19.000Z daily 0.75 https://www.medxy.ai/news/ja/muscle-fat-accumulation 2026-03-10T15:20:22.000Z daily 0.75 https://www.medxy.ai/news/zh/intralipid-accumulation-peripheral-artery-disease 2026-03-10T15:20:27.000Z daily 0.75 https://www.medxy.ai/news/misaligned-urgency 2026-03-10T14:48:15.000Z daily 0.75 https://www.medxy.ai/news/vi/inappropriate-urgency 2026-03-10T15:20:34.000Z daily 0.75 https://www.medxy.ai/news/ja/priority-mismatch-in-pediatric-heart-transplants 2026-03-10T15:20:41.000Z daily 0.75 https://www.medxy.ai/news/zh/misaligned-priorities 2026-03-10T15:20:45.000Z daily 0.75 https://www.medxy.ai/news/beyond-the-culprit 2026-03-10T15:14:38.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-crime-silent-plaque 2026-03-10T15:20:49.000Z daily 0.75 https://www.medxy.ai/news/ja/uncovering-asymptomatic-plaque-rupture 2026-03-11T22:27:54.000Z daily 0.75 https://www.medxy.ai/news/clinical-factors-biomarkers-pregnancy 2026-03-11T22:27:44.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-criminals-asymptomatic-plaque-rupture 2026-03-11T22:27:38.000Z daily 0.75 https://www.medxy.ai/news/vi/clinical-factors-pregnancy-cardiovascular-risk 2026-03-11T22:27:26.000Z daily 0.75 https://www.medxy.ai/news/ja/clinical-factors-biomarkers-cvd-risk 2026-03-11T22:27:18.000Z daily 0.75 https://www.medxy.ai/news/zh/clinical-factors-biomarkers-pregnancy-2 2026-03-11T22:27:07.000Z daily 0.75 https://www.medxy.ai/news/inclisiran-ldl-management 2026-03-10T15:27:22.000Z daily 0.75 https://www.medxy.ai/news/vi/inclisiran-ldl-c-management 2026-03-11T22:26:57.000Z daily 0.75 https://www.medxy.ai/news/ja/icr-ldl-c-management 2026-03-11T22:26:48.000Z daily 0.75 https://www.medxy.ai/news/zh/inclisiran-orion-16-study 2026-03-11T22:26:42.000Z daily 0.75 https://www.medxy.ai/news/glycemic-control-dialysis 2026-03-10T16:19:36.000Z daily 0.75 https://www.medxy.ai/news/vi/blood-sugar-control-dialysis 2026-03-11T22:26:25.000Z daily 0.75 https://www.medxy.ai/news/ja/blood-sugar-management-during-dialysis 2026-03-11T22:21:48.000Z daily 0.75 https://www.medxy.ai/news/zh/blood-glucose-control 2026-03-11T22:21:54.000Z daily 0.75 https://www.medxy.ai/news/ogtt-surrogate-indexes 2026-03-10T17:20:42.000Z daily 0.75 https://www.medxy.ai/news/vi/ogtt-alternative-indicators 2026-03-11T22:21:17.000Z daily 0.75 https://www.medxy.ai/news/ja/ogtt-alternative-indicator 2026-03-11T22:21:27.000Z daily 0.75 https://www.medxy.ai/news/zh/ogtt-alternative-index-diabetes-risk 2026-03-11T22:21:05.000Z daily 0.75 https://www.medxy.ai/news/chrono-nutrition-gestational-diabetes 2026-03-11T22:20:51.000Z daily 0.75 https://www.medxy.ai/news/vi/early-breakfast-diabetes-control 2026-03-11T22:20:45.000Z daily 0.75 https://www.medxy.ai/news/ja/gestational-diabetes-nutrition 2026-03-11T22:20:40.000Z daily 0.75 https://www.medxy.ai/news/zh/gestational-diabetes-timing-nutrition 2026-03-11T22:20:30.000Z daily 0.75 https://www.medxy.ai/news/aging-iodine-thyrotropin-dynamics 2026-03-11T22:20:23.000Z daily 0.75 https://www.medxy.ai/news/vi/aging-iodine-interaction-tsh 2026-03-11T22:20:17.000Z daily 0.75 https://www.medxy.ai/news/ja/aging-iodine-excess-thyroid-interaction 2026-03-11T22:20:09.000Z daily 0.75 https://www.medxy.ai/news/zh/aging-iodine-excess-hormone-analysis 2026-03-11T22:20:04.000Z daily 0.75 https://www.medxy.ai/news/paramagnetic-rim-lesions-ms-diagnosis 2026-03-11T22:19:53.000Z daily 0.75 https://www.medxy.ai/news/vi/early-diagnosis-model-sclerosis 2026-03-11T22:19:44.000Z daily 0.75 https://www.medxy.ai/news/ja/radiology-isolated-syndrome 2026-03-11T22:19:22.000Z daily 0.75 https://www.medxy.ai/news/zh/prognostic-significance-magnetic-lesions 2026-03-11T22:19:14.000Z daily 0.75 https://www.medxy.ai/news/beyond-recanalization-no-reflow 2026-03-10T18:24:20.000Z daily 0.75 https://www.medxy.ai/news/vi/reperfusion-understanding-dynamic-progress 2026-03-11T22:18:56.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-recirculation 2026-03-11T22:18:41.000Z daily 0.75 https://www.medxy.ai/news/zh/understanding-reflow-phenomenon 2026-03-11T22:18:34.000Z daily 0.75 https://www.medxy.ai/news/fkbp5-impact-stroke-recovery 2026-03-10T18:42:36.000Z daily 0.75 https://www.medxy.ai/news/vi/fkbp5-gen-stroke-recovery 2026-03-11T22:18:16.000Z daily 0.75 https://www.medxy.ai/news/ja/fkbp5-gene-stroke-recovery 2026-03-11T22:18:20.000Z daily 0.75 https://www.medxy.ai/news/artificial-intelligence-gastric-endoscopy 2026-03-11T22:17:48.000Z daily 0.75 https://www.medxy.ai/news/vi/artificial-intelligence-gastrointestinal-endoscopy 2026-03-11T22:17:41.000Z daily 0.75 https://www.medxy.ai/news/ja/ai-in-gastroscopy-results 2026-03-11T22:17:30.000Z daily 0.75 https://www.medxy.ai/news/zh/ai-gastrointestinal-endoscopy 2026-03-11T22:17:23.000Z daily 0.75 https://www.medxy.ai/news/universal-esd-cancer-resection 2026-03-10T19:17:40.000Z daily 0.75 https://www.medxy.ai/news/vi/endoscopic-surgery-barrett-cancer 2026-03-11T22:17:15.000Z daily 0.75 https://www.medxy.ai/news/ja/universal-surgery-cancer 2026-03-11T22:17:03.000Z daily 0.75 https://www.medxy.ai/news/zh/submucosal-dissection-barretts-cancer 2026-03-11T22:16:55.000Z daily 0.75 https://www.medxy.ai/news/taf2-hepatocellular-homeostasis 2026-03-11T22:16:46.000Z daily 0.75 https://www.medxy.ai/news/vi/taf2-and-liver-cancer 2026-03-11T22:16:38.000Z daily 0.75 https://www.medxy.ai/news/ja/taf2-in-liver-cancer 2026-03-11T22:16:31.000Z daily 0.75 https://www.medxy.ai/news/zh/taf2-liver-cancer-role 2026-03-11T22:16:23.000Z daily 0.75 https://www.medxy.ai/news/severe-obesity-heart-failure 2026-03-11T10:08:07.000Z daily 0.75 https://www.medxy.ai/news/vi/obesity-heart-failure-research 2026-03-11T22:16:14.000Z daily 0.75 https://www.medxy.ai/news/zh/obesity-heart-failure-risk-2 2026-03-11T22:15:59.000Z daily 0.75 https://www.medxy.ai/news/genetic-stratification-marfan-syndrome 2026-03-11T10:14:52.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-aorta-reevaluating-mitral-risk 2026-03-11T22:15:46.000Z daily 0.75 https://www.medxy.ai/news/ja/aortic-implications-marfan-syndrome 2026-03-11T22:15:36.000Z daily 0.75 https://www.medxy.ai/news/zh/aortopathy-gene-risk 2026-03-11T22:15:29.000Z daily 0.75 https://www.medxy.ai/news/handheld-device-success-rate 2026-03-11T10:53:04.000Z daily 0.75 https://www.medxy.ai/news/vi/new-mobile-device-success 2026-03-11T22:15:11.000Z daily 0.75 https://www.medxy.ai/news/zh/valsava-tech-success-rate 2026-03-11T22:15:16.000Z daily 0.75 https://www.medxy.ai/news/maternal-glycemic-control-gestational-diabetes 2026-03-11T11:39:46.000Z daily 0.75 https://www.medxy.ai/news/long-acting-growth-hormone-impact 2026-03-11T22:14:47.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-effects-growth-hormone 2026-03-11T22:14:39.000Z daily 0.75 https://www.medxy.ai/news/ja/height-gain-hormone-impact 2026-03-11T22:14:31.000Z daily 0.75 https://www.medxy.ai/news/zh/growth-hormone-impact 2026-03-11T22:14:24.000Z daily 0.75 https://www.medxy.ai/news/thyroid-cancer-evaluation 2026-03-11T22:14:15.000Z daily 0.75 https://www.medxy.ai/news/vi/enhancing-thyroid-cancer-qol 2026-03-11T22:13:51.000Z daily 0.75 https://www.medxy.ai/news/ja/thyroid-cancer-health-economics 2026-03-11T22:13:45.000Z daily 0.75 https://www.medxy.ai/news/zh/thyroid-cancer-economics 2026-03-11T22:13:38.000Z daily 0.75 https://www.medxy.ai/news/spinal-cord-tau-pathologies 2026-03-11T12:40:50.000Z daily 0.75 https://www.medxy.ai/news/motor-vehicle-accidents-falls-tbi-recovery 2026-03-11T13:54:31.000Z daily 0.75 https://www.medxy.ai/news/vi/traffic-accidents-and-falls 2026-03-11T22:13:30.000Z daily 0.75 https://www.medxy.ai/news/ja/traffic-accidents-tbi-recovery 2026-03-11T22:13:23.000Z daily 0.75 https://www.medxy.ai/news/zh/vehicle-accidents-and-falls 2026-03-11T22:13:16.000Z daily 0.75 https://www.medxy.ai/news/purine-enzyme-dna-damage 2026-03-11T22:13:02.000Z daily 0.75 https://www.medxy.ai/news/vi/paics-enzyme-dna-damage 2026-03-11T22:12:57.000Z daily 0.75 https://www.medxy.ai/news/ja/c9orf72-als-paics 2026-03-11T22:12:52.000Z daily 0.75 https://www.medxy.ai/news/zh/paics-als-dna-damage 2026-03-11T22:12:47.000Z daily 0.75 https://www.medxy.ai/news/revascularization-veretbral-occlusion 2026-03-11T22:12:38.000Z daily 0.75 https://www.medxy.ai/news/vi/vertebral-artery-revascularization 2026-03-11T22:12:30.000Z daily 0.75 https://www.medxy.ai/news/ja/revascularization-strategies-bravo-study 2026-03-11T22:12:21.000Z daily 0.75 https://www.medxy.ai/news/zh/isolated-vertebral-artery-revascularization 2026-03-11T22:12:12.000Z daily 0.75 https://www.medxy.ai/news/targeted-gut-liver-modulation 2026-03-11T22:12:03.000Z daily 0.75 https://www.medxy.ai/news/vi/liver-intestine-targets 2026-03-11T22:11:50.000Z daily 0.75 https://www.medxy.ai/news/ja/targeted-intestinal-liver-axis 2026-03-11T22:11:39.000Z daily 0.75 https://www.medxy.ai/news/zh/targeting-intestinal-liver-axis 2026-03-11T22:11:28.000Z daily 0.75 https://www.medxy.ai/news/gut-muscle-axis-roseburia 2026-03-11T22:11:16.000Z daily 0.75 https://www.medxy.ai/news/vi/roseburia-bone-strength 2026-03-11T22:11:06.000Z daily 0.75 https://www.medxy.ai/news/ja/intestinal-muscle-axis 2026-03-11T22:10:56.000Z daily 0.75 https://www.medxy.ai/news/zh/gut-muscle-axis-inulinivorans 2026-03-11T22:10:47.000Z daily 0.75 https://www.medxy.ai/news/toxicity-and-efficacy 2026-03-11T18:03:53.000Z daily 0.75 https://www.medxy.ai/news/vi/toxicity-and-survival-himalaya 2026-03-11T22:10:31.000Z daily 0.75 https://www.medxy.ai/news/ja/toxic-effects-himalaya-study 2026-03-11T22:10:25.000Z daily 0.75 https://www.medxy.ai/news/zh/toxicity-as-surrogate-indicator 2026-03-11T22:10:12.000Z daily 0.75 https://www.medxy.ai/news/cxcr6-therapeutic-frontier 2026-03-11T22:10:16.000Z daily 0.75 https://www.medxy.ai/news/vi/cxcr6-target-therapy 2026-03-11T22:09:56.000Z daily 0.75 https://www.medxy.ai/news/ja/cxcr6-targeting-heart-inflammation 2026-03-11T22:09:47.000Z daily 0.75 https://www.medxy.ai/news/zh/cxcr6-targeting-myocarditis 2026-03-11T22:09:41.000Z daily 0.75 https://www.medxy.ai/news/single-ventricle-reconstruction 2026-03-11T18:32:18.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-outcomes-univentricular-repair 2026-03-11T22:09:30.000Z daily 0.75 https://www.medxy.ai/news/ja/single-ventricle-reconstruction-2 2026-03-11T22:09:26.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-impact-of-single-ventricle-reconstruction 2026-03-11T22:09:19.000Z daily 0.75 https://www.medxy.ai/news/heart-failure-risk-model 2026-03-11T18:38:26.000Z daily 0.75 https://www.medxy.ai/news/zh/predicting-heart-failure 2026-03-11T22:09:10.000Z daily 0.75 https://www.medxy.ai/news/vi/heart-failure-prediction 2026-03-11T22:09:01.000Z daily 0.75 https://www.medxy.ai/news/ja/heart-failure-risk-model-2 2026-03-11T22:08:55.000Z daily 0.75 https://www.medxy.ai/news/beyond-stenosis-prognosis 2026-03-11T22:08:50.000Z daily 0.75 https://www.medxy.ai/news/vi/sau-hen-hep-plaque-impact 2026-03-11T22:08:45.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-narrowing-prognostic-impact 2026-03-11T22:08:40.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-narrowness-plaque-volume 2026-03-11T22:08:33.000Z daily 0.75 https://www.medxy.ai/news/tirzepatide-vs-dulaglutide 2025-12-18T19:24:22.000Z daily 0.75 https://www.medxy.ai/news/vi/tirzepatide-vs-dulaglutide-6 2026-03-11T22:08:20.000Z daily 0.75 https://www.medxy.ai/news/ja/tirzepatide-vs-dulaglutide-5 2026-03-11T22:08:24.000Z daily 0.75 https://www.medxy.ai/news/zh/xipapetide-vs-dulaglutide 2026-03-11T22:08:28.000Z daily 0.75 https://www.medxy.ai/news/distinctive-endocrine-profiles 2026-03-11T22:07:45.000Z daily 0.75 https://www.medxy.ai/news/vi/endocrine-profile-prader-willi 2026-03-11T22:07:35.000Z daily 0.75 https://www.medxy.ai/news/ja/rare-genetic-disorder-endocrine-profile 2026-03-11T22:07:27.000Z daily 0.75 https://www.medxy.ai/news/zh/rare-endocrine-features 2026-03-11T22:07:16.000Z daily 0.75 https://www.medxy.ai/news/long-term-thyroid-toxicity 2026-03-11T22:06:45.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-thyroid-toxicity-children 2026-03-11T22:06:33.000Z daily 0.75 https://www.medxy.ai/news/ja/high-risk-neuroblastoma-thyroid-toxicity 2026-03-11T22:06:23.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-thyroid-toxicity-children-2 2026-03-11T22:06:16.000Z daily 0.75 https://www.medxy.ai/news/ebna-1-antibodies-biomarker 2026-03-11T22:01:53.000Z daily 0.75 https://www.medxy.ai/news/vi/ebna-1-high-antibodies 2026-03-11T22:05:58.000Z daily 0.75 https://www.medxy.ai/news/ja/ebna-1-antibody-biomarker-2 2026-03-11T22:28:11.000Z daily 0.75 https://www.medxy.ai/news/zh/ebna-1-antibody-biomarker 2026-03-11T22:28:18.000Z daily 0.75 https://www.medxy.ai/news/sport-head-exposure-outcomes 2026-03-11T22:14:11.000Z daily 0.75 https://www.medxy.ai/news/optimizing-stroke-management 2026-03-11T22:28:32.000Z daily 0.75 https://www.medxy.ai/news/vi/hospital-funding-optimization 2026-03-11T22:29:27.000Z daily 0.75 https://www.medxy.ai/news/ja/emergency-route-optimization 2026-03-12T10:33:12.000Z daily 0.75 https://www.medxy.ai/news/zh/pre-hospital-optimization-iran-stroke 2026-03-12T10:33:06.000Z daily 0.75 https://www.medxy.ai/news/kynase-switch-t-cell-rescue 2026-03-12T08:19:24.000Z daily 0.75 https://www.medxy.ai/news/sonia-trial-cdk46-results 2026-03-12T10:32:53.000Z daily 0.75 https://www.medxy.ai/news/vi/reassessing-top-standards-cdk4-6 2026-03-12T10:32:45.000Z daily 0.75 https://www.medxy.ai/news/ja/reconsidering-frontline-standards 2026-03-12T10:32:36.000Z daily 0.75 https://www.medxy.ai/news/zh/rethinking-first-line-standards 2026-03-12T10:32:27.000Z daily 0.75 https://www.medxy.ai/news/trim28-e3-ligase-ferroptosis 2026-03-12T10:32:03.000Z daily 0.75 https://www.medxy.ai/news/vi/trim28-e3-ligase-heart-protection 2026-03-13T10:06:23.000Z daily 0.75 https://www.medxy.ai/news/ja/trim28-ferroptosis-prevention 2026-03-13T10:06:06.000Z daily 0.75 https://www.medxy.ai/news/zh/trim28-e3-ubiquitin-ligase 2026-03-13T10:06:00.000Z daily 0.75 https://www.medxy.ai/news/glp-1-receptor-agonists-prevention 2026-03-12T10:57:27.000Z daily 0.75 https://www.medxy.ai/news/vi/glp-1-receptor-agonists 2026-03-13T10:05:53.000Z daily 0.75 https://www.medxy.ai/news/ja/glp-1-drugs-cardiovascular-risk 2026-03-13T10:05:42.000Z daily 0.75 https://www.medxy.ai/news/zh/glp-1-receptor-agonists-primary-prevention 2026-03-13T10:05:35.000Z daily 0.75 https://www.medxy.ai/news/optimized-heart-failure-therapy 2026-03-12T11:24:20.000Z daily 0.75 https://www.medxy.ai/news/vi/optimal-heart-failure-cancer 2026-03-13T10:05:21.000Z daily 0.75 https://www.medxy.ai/news/ja/end-stage-cancer-heart-failure 2026-03-13T10:05:13.000Z daily 0.75 https://www.medxy.ai/news/zh/optimizing-heart-failure-treatment 2026-03-13T10:05:04.000Z daily 0.75 https://www.medxy.ai/news/abelacimab-safety-at-atrial-fibrillation 2026-03-12T11:32:21.000Z daily 0.75 https://www.medxy.ai/news/relacorilant-hypertension-cushing-syndrome 2026-03-12T11:57:43.000Z daily 0.75 https://www.medxy.ai/news/vi/relacorilant-cushing-blood-pressure 2026-03-13T10:04:51.000Z daily 0.75 https://www.medxy.ai/news/ja/lilacorin-and-hypertension 2026-03-13T10:04:45.000Z daily 0.75 https://www.medxy.ai/news/zh/relacorilant-cushing-hypertension 2026-03-13T10:04:31.000Z daily 0.75 https://www.medxy.ai/news/lifestyle-determinants-diabetes-pregnancy 2026-03-13T10:04:15.000Z daily 0.75 https://www.medxy.ai/news/vi/lifestyle-factors-diabetes-pregnancy 2026-03-13T10:04:06.000Z daily 0.75 https://www.medxy.ai/news/ja/type-1-diabetes-pregnancy-factors 2026-03-13T10:03:55.000Z daily 0.75 https://www.medxy.ai/news/zh/lifestyle-factors-gestational-diabetes 2026-03-13T10:03:43.000Z daily 0.75 https://www.medxy.ai/news/lcms-ms-accuracy-congenital-adrenal-hyperplasia 2026-03-12T13:41:27.000Z daily 0.75 https://www.medxy.ai/news/vi/lcms-accuracy-screening 2026-03-13T10:03:21.000Z daily 0.75 https://www.medxy.ai/news/ja/lc-msms-adrenal-screening 2026-03-13T10:03:26.000Z daily 0.75 https://www.medxy.ai/news/zh/lc-ms-ms-adrenal-screening 2026-03-13T10:03:30.000Z daily 0.75 https://www.medxy.ai/news/empagliflozin-beta-cell-preservation 2026-03-13T10:02:51.000Z daily 0.75 https://www.medxy.ai/news/vi/benefits-of-empagliflozin 2026-03-13T10:02:46.000Z daily 0.75 https://www.medxy.ai/news/ja/metabolic-benefits-emagliflozin 2026-03-13T10:02:41.000Z daily 0.75 https://www.medxy.ai/news/zh/metabolic-benefits-dcg-engliflozin 2026-03-13T10:02:34.000Z daily 0.75 https://www.medxy.ai/news/levothyroxine-safety-midlife-women 2026-03-12T14:01:39.000Z daily 0.75 https://www.medxy.ai/news/vi/levothyroxine-safety-women 2026-03-13T10:02:20.000Z daily 0.75 https://www.medxy.ai/news/zh/midlife-women-thyroid-safety-2 2026-03-13T10:02:26.000Z daily 0.75 https://www.medxy.ai/news/predictive-biomarkers-pml 2026-03-13T10:01:53.000Z daily 0.75 https://www.medxy.ai/news/vi/biomarker-pml-t-cell-response 2026-03-13T10:01:47.000Z daily 0.75 https://www.medxy.ai/news/ja/pml-predictive-biomarkers 2026-03-13T10:01:41.000Z daily 0.75 https://www.medxy.ai/news/zh/pml-predictive-biomarkers-2 2026-03-13T10:01:34.000Z daily 0.75 https://www.medxy.ai/news/dementia-predictors-veterans 2026-03-12T17:15:22.000Z daily 0.75 https://www.medxy.ai/news/vi/old-injuries-dementia-predictions 2026-03-13T10:01:15.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-aging-dementia-veterans 2026-03-13T10:01:09.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-aging-trauma-mental-health 2026-03-13T10:01:03.000Z daily 0.75 https://www.medxy.ai/news/somatic-mosaicism-als 2026-03-12T17:37:00.000Z daily 0.75 https://www.medxy.ai/news/vi/somatic-mosaicism-als-2 2026-03-13T10:00:55.000Z daily 0.75 https://www.medxy.ai/news/ja/motor-cortex-somatic-mosaic 2026-03-13T10:00:48.000Z daily 0.75 https://www.medxy.ai/news/zh/somatic-chimerism-als 2026-03-13T10:00:42.000Z daily 0.75 https://www.medxy.ai/news/exoskeleton-therapy-stroke 2026-03-13T10:00:35.000Z daily 0.75 https://www.medxy.ai/news/vi/external-frame-therapy-arm-recovery 2026-03-13T10:00:25.000Z daily 0.75 https://www.medxy.ai/news/ja/exoskeleton-therapy-stroke-2 2026-03-13T10:00:15.000Z daily 0.75 https://www.medxy.ai/news/zh/exoskeleton-therapy-stroke-recovery 2026-03-13T09:59:59.000Z daily 0.75 https://www.medxy.ai/news/masld-clinical-pathway 2026-03-13T09:59:39.000Z daily 0.75 https://www.medxy.ai/news/zh/exploring-masld-frontiers 2026-03-13T09:59:30.000Z daily 0.75 https://www.medxy.ai/news/vi/new-masld-clinical-care-guide 2026-03-13T09:59:23.000Z daily 0.75 https://www.medxy.ai/news/ja/masld-clinical-pathways 2026-03-13T09:59:17.000Z daily 0.75 https://www.medxy.ai/news/rethinking-colonoscopy-urgency 2026-03-12T21:54:44.000Z daily 0.75 https://www.medxy.ai/news/vi/colonoscopy-urgency-fit 2026-03-13T09:59:00.000Z daily 0.75 https://www.medxy.ai/news/ja/fit-colonoscopy-urgency-revision 2026-03-13T09:59:05.000Z daily 0.75 https://www.medxy.ai/news/zh/rethinking-colonoscopy-urgency-2 2026-03-13T09:57:45.000Z daily 0.75 https://www.medxy.ai/news/metabolic-synergy-liver-disease 2026-03-13T09:57:33.000Z daily 0.75 https://www.medxy.ai/news/vi/metabolic-interaction-liver-disease 2026-03-13T09:57:29.000Z daily 0.75 https://www.medxy.ai/news/ja/metabolic-synergy-liver-disease-2 2026-03-13T09:57:21.000Z daily 0.75 https://www.medxy.ai/news/zh/metabolic-synergy-obesity-diabetes-liver-risk 2026-03-13T09:57:12.000Z daily 0.75 https://www.medxy.ai/news/tamoxifen-uterine-disease-risk 2026-03-13T09:56:53.000Z daily 0.75 https://www.medxy.ai/news/vi/tamoxifen-cervical-cancer-risk 2026-03-13T09:56:46.000Z daily 0.75 https://www.medxy.ai/news/ja/tamoxifen-uterine-disease-risk-2 2026-03-13T09:56:35.000Z daily 0.75 https://www.medxy.ai/news/zh/tamoxifen-breast-cancer-risk 2026-03-13T09:56:27.000Z daily 0.75 https://www.medxy.ai/news/epidural-anesthesia-vs-remifentanil 2026-03-13T09:56:14.000Z daily 0.75 https://www.medxy.ai/news/vi/epidural-analgesia-study 2026-03-13T09:56:07.000Z daily 0.75 https://www.medxy.ai/news/ja/epidural-vs-iv-remifentanil 2026-03-13T09:56:00.000Z daily 0.75 https://www.medxy.ai/news/zh/epidural-anesthesia-vs-iv-remifentanil 2026-03-13T09:55:56.000Z daily 0.75 https://www.medxy.ai/news/lymph-node-tumor-cells 2026-03-13T10:06:49.000Z daily 0.75 https://www.medxy.ai/news/vi/lymph-nodes-with-single-tumor-cells 2026-03-13T13:58:46.000Z daily 0.75 https://www.medxy.ai/news/ja/ovarian-cancer-lymph-nodes 2026-03-13T13:58:38.000Z daily 0.75 https://www.medxy.ai/news/zh/isolated-tumor-cells-ovarian-cancer 2026-03-13T13:58:25.000Z daily 0.75 https://www.medxy.ai/news/lower-mortality-transplant-center-surgery 2026-03-13T13:58:15.000Z daily 0.75 https://www.medxy.ai/news/vi/organ-transplant-surgery-outcomes 2026-03-13T13:58:05.000Z daily 0.75 https://www.medxy.ai/news/zh/low-mortality-transplant-surgery 2026-03-13T13:57:49.000Z daily 0.75 https://www.medxy.ai/news/long-term-survival-esophagectomy 2026-03-13T13:57:21.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-survival-vs-short-term-quality 2026-03-13T13:57:12.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-survival-esophagus-cancer 2026-03-13T13:57:03.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-survival-over-quality 2026-03-13T13:56:48.000Z daily 0.75 https://www.medxy.ai/news/laparoscopic-pancreatectomy-safety 2026-03-13T11:02:00.000Z daily 0.75 https://www.medxy.ai/news/vi/repeat-endoscopic-pancreatic-surgery 2026-03-13T13:56:33.000Z daily 0.75 https://www.medxy.ai/news/ja/laparoscopic-pancreatectomy-safety-2 2026-03-13T13:56:25.000Z daily 0.75 https://www.medxy.ai/news/zh/laparoscopic-pancreas-resection 2026-03-13T13:56:20.000Z daily 0.75 https://www.medxy.ai/news/neuropsychiatric-burden-botulinum-toxin 2026-03-13T13:56:12.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-cricothyroid-dilation 2026-03-13T13:56:01.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-bloating-botox-treatment 2026-03-13T13:55:38.000Z daily 0.75 https://www.medxy.ai/news/new-standard-pediatric-vocal-fold-immobility 2026-03-13T13:55:29.000Z daily 0.75 https://www.medxy.ai/news/vi/new-standards-pediatric-voice-recovery 2026-03-13T13:55:16.000Z daily 0.75 https://www.medxy.ai/news/ja/new-standards-for-pediatric-voice-surgery 2026-03-13T13:55:20.000Z daily 0.75 https://www.medxy.ai/news/zh/cardiac-surgery-pediatric-voice 2026-03-13T13:55:24.000Z daily 0.75 https://www.medxy.ai/news/beyond-cornea-cardiometabolic-burden 2026-03-13T13:54:32.000Z daily 0.75 https://www.medxy.ai/news/vi/corneal-dystrophy-cardiovascular-burden 2026-03-13T13:54:38.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-the-cornea 2026-03-13T13:54:12.000Z daily 0.75 https://www.medxy.ai/news/policy-shifts-penicillin-allergy-cataract-surgery 2026-03-13T12:35:46.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-corneal-dystrophy 2026-03-13T13:54:19.000Z daily 0.75 https://www.medxy.ai/news/vi/penicillin-allergy-policy-cefuroxime-use 2026-03-13T13:53:47.000Z daily 0.75 https://www.medxy.ai/news/ja/penicillin-allergy-policy-change 2026-03-13T13:53:36.000Z daily 0.75 https://www.medxy.ai/news/high-frequency-tens-nociplastic-pain 2026-03-13T12:42:56.000Z daily 0.75 https://www.medxy.ai/news/zh/new-guidelines-cefazolin-use 2026-03-13T13:53:29.000Z daily 0.75 https://www.medxy.ai/news/vi/high-frequency-tens-promise-pain 2026-03-13T13:53:18.000Z daily 0.75 https://www.medxy.ai/news/ja/high-frequency-tens-results 2026-03-13T13:53:09.000Z daily 0.75 https://www.medxy.ai/news/zh/high-frequency-tens-nociplastic-eye-pain 2026-03-13T13:53:02.000Z daily 0.75 https://www.medxy.ai/news/preclinical-lung-function-decline 2026-03-13T13:59:02.000Z daily 0.75 https://www.medxy.ai/news/vi/preclinical-stage-format 2026-03-13T13:59:08.000Z daily 0.75 https://www.medxy.ai/news/ja/preclinical-mapping-ipf-lung-function 2026-03-13T14:00:58.000Z daily 0.75 https://www.medxy.ai/news/zh/preclinical-iph-symptoms 2026-03-13T14:00:50.000Z daily 0.75 https://www.medxy.ai/news/nocturnal-hypoxemia-survival-lung-cancer 2026-03-13T13:59:24.000Z daily 0.75 https://www.medxy.ai/news/vi/nighttime-respiratory-failure 2026-03-13T14:40:55.000Z daily 0.75 https://www.medxy.ai/news/ja/factors-affecting-survival-nsclc 2026-03-13T14:40:49.000Z daily 0.75 https://www.medxy.ai/news/zh/severe-nocturnal-hypoxemia-non-small-cell-lung-cancer 2026-03-13T14:40:43.000Z daily 0.75 https://www.medxy.ai/news/anti-bcma-infection-risk 2026-03-13T14:41:06.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-cytoplasm-why-bcma-antibodies-increase-infection-risk 2026-03-13T14:41:10.000Z daily 0.75 https://www.medxy.ai/news/ja/plasma-cell-exceeding-b-cell-depletion 2026-03-13T14:41:25.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-plasma-cells 2026-03-15T21:09:19.000Z daily 0.75 https://www.medxy.ai/news/molecular-features-lymphoma-prognosis 2026-03-13T14:56:39.000Z daily 0.75 https://www.medxy.ai/news/vi/complexity-and-molecular-features 2026-03-15T21:09:09.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-complexity-molecular-features-llc 2026-03-15T21:09:03.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-complexity-cll-prognosis 2026-03-15T21:08:54.000Z daily 0.75 https://www.medxy.ai/news/precision-dosing-cml-tki 2026-03-15T21:08:49.000Z daily 0.75 https://www.medxy.ai/news/vi/precision-dosing-chronic-myeloid-leukemia 2026-03-15T21:08:43.000Z daily 0.75 https://www.medxy.ai/news/ja/chronic-myeloid-leukemia-dosing 2026-03-15T21:08:35.000Z daily 0.75 https://www.medxy.ai/news/zh/chronic-myeloid-leukemia-targeted-therapy 2026-03-15T21:08:31.000Z daily 0.75 https://www.medxy.ai/news/standardizing-outcomes-research 2026-03-15T21:08:25.000Z daily 0.75 https://www.medxy.ai/news/vi/standardizing-research-results 2026-03-15T21:08:20.000Z daily 0.75 https://www.medxy.ai/news/ja/stem-cell-transplant-data-standardization 2026-03-15T21:08:13.000Z daily 0.75 https://www.medxy.ai/news/zh/standardized-results-study 2026-03-15T21:08:07.000Z daily 0.75 https://www.medxy.ai/news/metformin-ursodeoxycholic-acid-failure 2026-03-13T22:41:26.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-ursodeoxycholic-acid-covid-recovery 2026-03-15T21:07:57.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-ursodeoxycholic-acid-covid-recovery-3 2026-03-15T21:07:51.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-ursodeoxycholic-acid-covid-recovery-2 2026-03-15T21:07:44.000Z daily 0.75 https://www.medxy.ai/news/sglt2-vs-glp1-kidney-outcomes 2026-03-15T21:07:35.000Z daily 0.75 https://www.medxy.ai/news/vi/sglt2-glp1-kidney-comparison 2026-03-15T21:07:28.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-glp1-diabetes-kidney-impact 2026-03-15T21:07:19.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-glp1-kidney-outcomes 2026-03-15T21:07:13.000Z daily 0.75 https://www.medxy.ai/news/pace-it-model 2026-03-14T12:55:13.000Z daily 0.75 https://www.medxy.ai/news/pace-it-model-multimorbidity 2026-03-14T12:57:51.000Z daily 0.75 https://www.medxy.ai/news/vi/breaking-silos-pace-it 2026-03-15T21:04:22.000Z daily 0.75 https://www.medxy.ai/news/ja/breaking-siloeze 2026-03-15T21:04:04.000Z daily 0.75 https://www.medxy.ai/news/zh/breaking-barriers-pace-it-model 2026-03-15T21:03:49.000Z daily 0.75 https://www.medxy.ai/news/emergency-care-assessment 2026-03-14T13:03:57.000Z daily 0.75 https://www.medxy.ai/news/zh/emergency-nursing-gap 2026-03-15T21:03:33.000Z daily 0.75 https://www.medxy.ai/news/ja/overcoming-gaps-in-pediatric-emergency-care 2026-03-15T21:03:23.000Z daily 0.75 https://www.medxy.ai/news/ems-pediatric-readiness 2026-03-14T13:09:07.000Z daily 0.75 https://www.medxy.ai/news/zh/strengthening-safety-net 2026-03-15T21:03:09.000Z daily 0.75 https://www.medxy.ai/news/vi/strengthening-safety-system 2026-03-15T21:03:02.000Z daily 0.75 https://www.medxy.ai/news/antipsychotics-icu-catatonia 2026-03-14T13:15:08.000Z daily 0.75 https://www.medxy.ai/news/ja/emergency-care-insights 2026-03-15T21:02:47.000Z daily 0.75 https://www.medxy.ai/news/malignancy-risk-transplant-recipients 2026-03-15T21:02:42.000Z daily 0.75 https://www.medxy.ai/news/vi/cancer-risk-model-transplant-recipients 2026-03-15T21:02:30.000Z daily 0.75 https://www.medxy.ai/news/ja/cancer-risk-patterns-organ-transplant 2026-03-15T21:02:20.000Z daily 0.75 https://www.medxy.ai/news/zh/cancer-risk-patterns 2026-03-15T21:02:10.000Z daily 0.75 https://www.medxy.ai/news/adipocyte-cardiomyocyte-communication 2026-03-15T21:01:55.000Z daily 0.75 https://www.medxy.ai/news/vi/adiponectin-heart-cell-communication 2026-03-15T21:01:49.000Z daily 0.75 https://www.medxy.ai/news/ja/extracellular-adiponectin-signaling 2026-03-15T21:01:43.000Z daily 0.75 https://www.medxy.ai/news/zh/adipocyte-myocyte-communication 2026-03-15T21:01:33.000Z daily 0.75 https://www.medxy.ai/news/efficiency-unleashed-heart-teams 2026-03-15T21:01:06.000Z daily 0.75 https://www.medxy.ai/news/vi/efficiency-unleashed-cad-management 2026-03-15T21:01:01.000Z daily 0.75 https://www.medxy.ai/news/ja/efficiency-unleashed 2026-03-15T21:00:57.000Z daily 0.75 https://www.medxy.ai/news/zh/efficiency-release-eheart-trial 2026-03-15T21:00:41.000Z daily 0.75 https://www.medxy.ai/news/moderate-aortic-valve-disease 2026-03-14T22:11:03.000Z daily 0.75 https://www.medxy.ai/news/vi/aortic-valve-disease-risks 2026-03-15T21:00:35.000Z daily 0.75 https://www.medxy.ai/news/zh/moderate-aortic-valve-disease-2 2026-03-15T21:00:25.000Z daily 0.75 https://www.medxy.ai/news/residual-risk-hfref-2 2026-03-15T21:00:16.000Z daily 0.75 https://www.medxy.ai/news/vi/remaining-clinical-risks-hfref 2026-03-15T21:00:12.000Z daily 0.75 https://www.medxy.ai/news/ja/hfrefrisk-economic-burden 2026-03-15T21:00:08.000Z daily 0.75 https://www.medxy.ai/news/zh/hfrefr-remaining-risks 2026-03-15T21:00:02.000Z daily 0.75 https://www.medxy.ai/news/mortality-shift-diabetes 2026-03-15T20:59:57.000Z daily 0.75 https://www.medxy.ai/news/vi/diabetes-death-trends 2026-03-15T20:59:51.000Z daily 0.75 https://www.medxy.ai/news/zh/diabetes-mortality-changes-2 2026-03-15T20:59:40.000Z daily 0.75 https://www.medxy.ai/news/chronic-inflammation-supar 2026-03-14T23:06:31.000Z daily 0.75 https://www.medxy.ai/news/vi/chronic-inflammation-supar-2 2026-03-15T20:59:30.000Z daily 0.75 https://www.medxy.ai/news/zh/supar-%25e6%2585%25a2%25e6%2580%25a7%25e7%2582%258e%25e7%2597%2587-%25e7%25b3%2596%25e5%25b0%25bf%25e7%2597%2585-%25e5%25bf%2583%25e8%25a1%2580%25e7%25ae%25a1%25e6%25ad%25bb%25e4%25ba%25a1%25e7%258e%2587 2026-03-15T20:59:19.000Z daily 0.75 https://www.medxy.ai/news/decoding-camp-nexus 2026-03-14T23:14:33.000Z daily 0.75 https://www.medxy.ai/news/vi/decoding-camp-molecule-architecture 2026-03-15T20:59:06.000Z daily 0.75 https://www.medxy.ai/news/ja/camp-nexus-discovery 2026-03-15T20:59:01.000Z daily 0.75 https://www.medxy.ai/news/zh/decoding-camp-axis 2026-03-15T20:58:53.000Z daily 0.75 https://www.medxy.ai/news/sglt2-dietary-sodium-interaction 2026-03-15T20:58:48.000Z daily 0.75 https://www.medxy.ai/news/vi/sglt2-inhibition-natri-interaction 2026-03-15T20:58:43.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-inhibitors-sodium-interaction 2026-03-15T20:58:38.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-sodium-interaction 2026-03-15T20:58:33.000Z daily 0.75 https://www.medxy.ai/news/long-term-quality-of-life-thyroid-cancer 2026-03-15T08:27:36.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-quality-life-thyroid-cancer 2026-03-15T20:58:22.000Z daily 0.75 https://www.medxy.ai/news/ja/low-risk-thyroid-cancer-quality-of-life-2 2026-03-15T20:58:14.000Z daily 0.75 https://www.medxy.ai/news/zh/low-risk-thyroid-cancer-quality 2026-03-15T20:58:08.000Z daily 0.75 https://www.medxy.ai/news/cognitive-decline-interplay 2026-03-15T20:57:49.000Z daily 0.75 https://www.medxy.ai/news/vi/distinguishing-cognitive-decline 2026-03-15T20:57:43.000Z daily 0.75 https://www.medxy.ai/news/ja/cognitive-decline-amiloid-negative 2026-03-15T20:57:36.000Z daily 0.75 https://www.medxy.ai/news/zh/cognitive-decline-interaction 2026-03-15T20:57:29.000Z daily 0.75 https://www.medxy.ai/news/nihss-bias-stroke-risks 2026-03-15T17:52:28.000Z daily 0.75 https://www.medxy.ai/news/vi/nihss-bias-stroke-risk 2026-03-15T20:56:47.000Z daily 0.75 https://www.medxy.ai/news/ja/nihss-bias-right-stroke 2026-03-15T20:56:52.000Z daily 0.75 https://www.medxy.ai/news/zh/nihss-bias-right-hemisphere-stroke 2026-03-15T20:57:01.000Z daily 0.75 https://www.medxy.ai/news/sox9-chemoresistance-reversal 2026-03-15T20:51:40.000Z daily 0.75 https://www.medxy.ai/news/vi/sox9-chemoresistance-reversal-2 2026-03-15T20:51:33.000Z daily 0.75 https://www.medxy.ai/news/zh/reverse-esophageal-cancer-resistance 2026-03-15T20:51:22.000Z daily 0.75 https://www.medxy.ai/news/acute-gi-bleeding-management 2026-03-15T18:51:11.000Z daily 0.75 https://www.medxy.ai/news/zh/acute-gi-bleeding-management-2 2026-03-15T20:51:04.000Z daily 0.75 https://www.medxy.ai/news/vi/evolution-of-gastrointestinal-bleeding-management 2026-03-15T20:51:08.000Z daily 0.75 https://www.medxy.ai/news/mri-radiomics-pathology-response 2026-03-15T20:50:44.000Z daily 0.75 https://www.medxy.ai/news/ja/acute-upper-gi-bleeding-management 2026-03-15T20:51:15.000Z daily 0.75 https://www.medxy.ai/news/vi/radiomic-predictive-ability-liver-cancer 2026-03-15T20:50:30.000Z daily 0.75 https://www.medxy.ai/news/ja/mri-radiomics-predicts-hcc 2026-03-15T20:50:23.000Z daily 0.75 https://www.medxy.ai/news/zh/mri-radiomics-prediction-liver-cancer 2026-03-15T20:50:12.000Z daily 0.75 https://www.medxy.ai/news/endometrial-polyps-management 2026-03-15T20:50:05.000Z daily 0.75 https://www.medxy.ai/news/vi/endometrial-polyp-management-3 2026-03-15T20:49:54.000Z daily 0.75 https://www.medxy.ai/news/ja/endometrial-polyp-management-2 2026-03-15T20:49:47.000Z daily 0.75 https://www.medxy.ai/news/zh/endometrial-polyp-management 2026-03-15T19:37:14.000Z daily 0.75 https://www.medxy.ai/news/de-escalation-radical-trachelectomy 2026-03-15T19:36:41.000Z daily 0.75 https://www.medxy.ai/news/vi/cervical-surgery-limitations 2026-03-15T20:49:36.000Z daily 0.75 https://www.medxy.ai/news/ja/shift-in-withdrawal-trend 2026-03-15T20:49:30.000Z daily 0.75 https://www.medxy.ai/news/zh/decreasing-importance-of-radical-hysterectomy 2026-03-15T20:49:18.000Z daily 0.75 https://www.medxy.ai/news/one-hour-glucose-predictor 2026-03-15T20:48:16.000Z daily 0.75 https://www.medxy.ai/news/vi/blood-glucose-levels-pcos 2026-03-15T21:09:51.000Z daily 0.75 https://www.medxy.ai/news/ja/1-hour-plasma-glucose-pcos 2026-03-15T21:10:01.000Z daily 0.75 https://www.medxy.ai/news/peritoneal-cancer-risk 2026-03-15T20:57:29.000Z daily 0.75 https://www.medxy.ai/news/survival-in-esophageal-cancer 2026-03-15T21:04:57.000Z daily 0.75 https://www.medxy.ai/news/vi/survival-unaffected-by-surgery-complications 2026-03-15T21:10:16.000Z daily 0.75 https://www.medxy.ai/news/ja/esophageal-cancer-surgery-complications 2026-03-18T12:37:03.000Z daily 0.75 https://www.medxy.ai/news/zh/jco-g1109-complications-survival 2026-03-18T12:36:59.000Z daily 0.75 https://www.medxy.ai/news/surgical-value-reforms 2026-03-18T12:36:55.000Z daily 0.75 https://www.medxy.ai/news/vi/surgical-models-impact 2026-03-18T12:36:49.000Z daily 0.75 https://www.medxy.ai/news/ja/surgical-value-evolution 2026-03-18T12:36:45.000Z daily 0.75 https://www.medxy.ai/news/zh/surgical-value-paradigm 2026-03-18T12:36:41.000Z daily 0.75 https://www.medxy.ai/news/molecular-profiling-vocal-lesions 2026-03-18T12:36:34.000Z daily 0.75 https://www.medxy.ai/news/vi/molecular-analysis-laryngeal-lesions 2026-03-18T12:36:29.000Z daily 0.75 https://www.medxy.ai/news/ja/benign-vocal-cord-profiling 2026-03-18T12:36:24.000Z daily 0.75 https://www.medxy.ai/news/zh/benign-vocal-cord-lesions 2026-03-18T12:36:20.000Z daily 0.75 https://www.medxy.ai/news/long-term-anti-vegf-cataract-impact 2026-03-16T11:42:39.000Z daily 0.75 https://www.medxy.ai/news/dual-sensory-impairment-rehabilitation 2026-03-18T12:36:14.000Z daily 0.75 https://www.medxy.ai/news/vi/impact-of-sensory-interference 2026-03-18T12:36:08.000Z daily 0.75 https://www.medxy.ai/news/ja/dual-sensory-disability-impact 2026-03-18T12:36:03.000Z daily 0.75 https://www.medxy.ai/news/zh/dual-sensory-disability-impact-2 2026-03-18T12:34:46.000Z daily 0.75 https://www.medxy.ai/news/microvascular-dropout-biomarker 2026-03-16T15:56:56.000Z daily 0.75 https://www.medxy.ai/news/vi/loss-of-microchip-glaucoma 2026-03-18T12:34:38.000Z daily 0.75 https://www.medxy.ai/news/ja/microvascular-drop-biomarker 2026-03-18T12:34:34.000Z daily 0.75 https://www.medxy.ai/news/zh/microvascular-loss-glaucoma-biomarker 2026-03-18T12:34:29.000Z daily 0.75 https://www.medxy.ai/news/nerandomilast-ipf-survival 2026-03-16T17:27:54.000Z daily 0.75 https://www.medxy.ai/news/vi/nerandomilast-ipf-survival-3 2026-03-18T12:34:18.000Z daily 0.75 https://www.medxy.ai/news/ja/nerandomilast-ipf-survival-2 2026-03-18T12:34:12.000Z daily 0.75 https://www.medxy.ai/news/zh/nerandomilast-ipf-application 2026-03-18T12:34:01.000Z daily 0.75 https://www.medxy.ai/news/prophylactic-haemostatic-strategies 2026-03-18T12:33:55.000Z daily 0.75 https://www.medxy.ai/news/vi/bleeding-prevention-strategy 2026-03-18T12:33:46.000Z daily 0.75 https://www.medxy.ai/news/ja/preventive-bleeding-strategies 2026-03-18T12:33:37.000Z daily 0.75 https://www.medxy.ai/news/zh/preventive-bleeding-strategies-2 2026-03-18T12:33:31.000Z daily 0.75 https://www.medxy.ai/news/glycan-signature-aml 2026-03-18T12:33:16.000Z daily 0.75 https://www.medxy.ai/news/vi/glycan-chondroitin-sulfate-leukemia 2026-03-18T12:33:08.000Z daily 0.75 https://www.medxy.ai/news/ja/targeting-sugar-signatures 2026-03-18T12:33:01.000Z daily 0.75 https://www.medxy.ai/news/zh/targeted-glycan-features 2026-03-18T12:32:53.000Z daily 0.75 https://www.medxy.ai/news/menin-inhibition-aml 2026-03-16T19:29:45.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-blast-count-aml 2026-03-18T12:32:43.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-cd34-and-survival 2026-03-18T12:32:30.000Z daily 0.75 https://www.medxy.ai/news/nsun2-fosb-loop 2026-03-18T12:32:24.000Z daily 0.75 https://www.medxy.ai/news/vi/nsun2-fosb-loop-2 2026-03-18T12:32:18.000Z daily 0.75 https://www.medxy.ai/news/ja/nsun2-fosb-loop-leukemia 2026-03-18T12:32:10.000Z daily 0.75 https://www.medxy.ai/news/zh/nsun2-fosb-loop-m5c-survival 2026-03-18T12:32:00.000Z daily 0.75 https://www.medxy.ai/news/tuberculosis-after-stem-cell-transplant 2026-03-18T12:31:55.000Z daily 0.75 https://www.medxy.ai/news/vi/lung-tb-post-stem-cell-transplant 2026-03-18T12:31:43.000Z daily 0.75 https://www.medxy.ai/news/ja/tuberculosis-after-hsct 2026-03-18T12:31:31.000Z daily 0.75 https://www.medxy.ai/news/zh/tb-after-transplant-study 2026-03-18T12:31:24.000Z daily 0.75 https://www.medxy.ai/news/influenza-protection-older-adults 2026-03-18T12:31:06.000Z daily 0.75 https://www.medxy.ai/news/vi/optimize-flu-protection-elderly-diabetes 2026-03-18T12:31:00.000Z daily 0.75 https://www.medxy.ai/news/ja/diabetes-influenza-prevention 2026-03-18T12:30:55.000Z daily 0.75 https://www.medxy.ai/news/zh/optimizing-flu-protection-elderly-diabetics 2026-03-18T12:30:50.000Z daily 0.75 https://www.medxy.ai/news/patient-voice-guidance 2026-03-17T12:08:58.000Z daily 0.75 https://www.medxy.ai/news/zh/strengthening-patient-voice 2026-03-18T12:30:44.000Z daily 0.75 https://www.medxy.ai/news/ja/patient-voice-enhancement 2026-03-18T12:30:39.000Z daily 0.75 https://www.medxy.ai/news/emergency-department-suicide-use 2026-03-17T14:27:38.000Z daily 0.75 https://www.medxy.ai/news/electrolyte-monitoring-icu 2026-03-18T12:30:23.000Z daily 0.75 https://www.medxy.ai/news/vi/electrolyte-monitoring-icu-3 2026-03-18T12:30:18.000Z daily 0.75 https://www.medxy.ai/news/ja/icu-electrolyte-monitoring 2026-03-18T12:30:12.000Z daily 0.75 https://www.medxy.ai/news/zh/electrolyte-monitoring-icu-2 2026-03-18T12:30:06.000Z daily 0.75 https://www.medxy.ai/news/crlf1-cardiac-fibroblasts-therapeutic-target 2026-03-17T15:12:03.000Z daily 0.75 https://www.medxy.ai/news/coronary-artery-calcium-scoring 2026-03-17T15:13:34.000Z daily 0.75 https://www.medxy.ai/news/vi/andong-calcification-assessment 2026-03-18T12:29:56.000Z daily 0.75 https://www.medxy.ai/news/ja/coronary-calcification-score 2026-03-18T12:29:52.000Z daily 0.75 https://www.medxy.ai/news/zh/coronary-calcification-score-2 2026-03-18T12:29:48.000Z daily 0.75 https://www.medxy.ai/news/tavi-superiority-women-aortic-stenosis 2026-03-17T17:59:36.000Z daily 0.75 https://www.medxy.ai/news/vi/tavi-in-women 2026-03-18T12:29:40.000Z daily 0.75 https://www.medxy.ai/news/ja/tavi-in-women-2 2026-03-18T12:29:37.000Z daily 0.75 https://www.medxy.ai/news/zh/tavi-in-women-aortic-stenosis 2026-03-18T12:29:31.000Z daily 0.75 https://www.medxy.ai/news/plasma-proteome-venous-thromboembolism 2026-03-18T12:29:27.000Z daily 0.75 https://www.medxy.ai/news/vi/plasma-proteome-mapping-thrombosis 2026-03-18T12:29:22.000Z daily 0.75 https://www.medxy.ai/news/ja/plasma-proteome-mapping 2026-03-18T12:29:17.000Z daily 0.75 https://www.medxy.ai/news/zh/plasma-proteomics-thrombosis 2026-03-18T12:29:12.000Z daily 0.75 https://www.medxy.ai/news/transcatheter-mitral-repair 2026-03-17T22:19:40.000Z daily 0.75 https://www.medxy.ai/news/vi/catheter-repair-mitral-regurgitation 2026-03-18T12:29:05.000Z daily 0.75 https://www.medxy.ai/news/ja/edge-to-edge-repair-superior 2026-03-18T12:29:02.000Z daily 0.75 https://www.medxy.ai/news/zh/treatment-of-mitral-regurgitation 2026-03-18T12:28:56.000Z daily 0.75 https://www.medxy.ai/news/ckm-syndrome-approach 2026-03-18T12:28:49.000Z daily 0.75 https://www.medxy.ai/news/vi/ckm-syndrome-summary 2026-03-18T12:28:40.000Z daily 0.75 https://www.medxy.ai/news/ja/ckm-syndrome-integration 2026-03-18T12:28:35.000Z daily 0.75 https://www.medxy.ai/news/zh/ckm-syndrome-trends 2026-03-18T12:28:28.000Z daily 0.75 https://www.medxy.ai/news/loxl2-inhibition-dilated-cardiomyopathy 2026-03-17T22:41:07.000Z daily 0.75 https://www.medxy.ai/news/vi/loxl2-inhibition-cardiac-hypertrophy 2026-03-18T12:28:14.000Z daily 0.75 https://www.medxy.ai/news/ja/loxl2-inhibition-heart-disease 2026-03-18T12:28:10.000Z daily 0.75 https://www.medxy.ai/news/zh/loxl2-inhibition-lmna-cardiomyopathy 2026-03-18T12:28:05.000Z daily 0.75 https://www.medxy.ai/news/time-below-range-predictor 2026-03-17T22:58:47.000Z daily 0.75 https://www.medxy.ai/news/vi/why-below-target-time-is-a-poor-predictor-of-severe-hypoglycemia 2026-03-18T12:27:59.000Z daily 0.75 https://www.medxy.ai/news/ja/why-time-below-range-is-an-inappropriate-predictor 2026-03-18T12:27:54.000Z daily 0.75 https://www.medxy.ai/news/zh/low-range-time-predictor 2026-03-18T12:27:50.000Z daily 0.75 https://www.medxy.ai/news/breaking-fasting-mandate 2026-03-18T06:39:42.000Z daily 0.75 https://www.medxy.ai/news/vi/breaking-fasting-requirements-levothyroxine 2026-03-18T12:27:43.000Z daily 0.75 https://www.medxy.ai/news/ja/breaking-fasting-obligation 2026-03-18T12:27:38.000Z daily 0.75 https://www.medxy.ai/news/zh/breaking-fasting-rules 2026-03-18T12:27:33.000Z daily 0.75 https://www.medxy.ai/news/glycemic-predictability-exercise 2026-03-18T12:27:27.000Z daily 0.75 https://www.medxy.ai/news/vi/optimize-glucose-prediction 2026-03-18T12:27:21.000Z daily 0.75 https://www.medxy.ai/news/ja/blood-sugar-prediction-optimization 2026-03-18T12:27:14.000Z daily 0.75 https://www.medxy.ai/news/zh/optimize-type-1-diabetes-blood-sugar 2026-03-18T12:26:50.000Z daily 0.75 https://www.medxy.ai/news/psychological-burden-thyroid-cancer 2026-03-18T12:27:08.000Z daily 0.75 https://www.medxy.ai/news/vi/mental-burden-cancer-survival 2026-03-18T12:26:39.000Z daily 0.75 https://www.medxy.ai/news/zh/thyroid-cancer-survival-psychological-burden 2026-03-18T12:26:30.000Z daily 0.75 https://www.medxy.ai/news/primec-als-trial-insights 2026-03-18T12:26:14.000Z daily 0.75 https://www.medxy.ai/news/vi/primec-als-benefits 2026-03-18T12:26:11.000Z daily 0.75 https://www.medxy.ai/news/ja/primec-als-study-insights 2026-03-18T12:26:05.000Z daily 0.75 https://www.medxy.ai/news/zh/primec-als-benefits-2 2026-03-18T12:26:00.000Z daily 0.75 https://www.medxy.ai/news/diagnostic-overlap-ms-antibody-testing 2026-03-18T12:25:52.000Z daily 0.75 https://www.medxy.ai/news/vi/navigating-overlap-diagnosis-nerve-inflammation 2026-03-18T12:25:49.000Z daily 0.75 https://www.medxy.ai/news/ja/overcoming-diagnostic-duplication 2026-03-18T12:25:42.000Z daily 0.75 https://www.medxy.ai/news/zh/overlap-in-diagnosis-ms 2026-03-18T12:25:36.000Z daily 0.75 https://www.medxy.ai/news/recent-infections-cryptogenic-stroke 2026-03-18T12:25:29.000Z daily 0.75 https://www.medxy.ai/news/vi/recent-infection-stroke-youth 2026-03-18T12:25:25.000Z daily 0.75 https://www.medxy.ai/news/ja/recent-infections-stroke-trigger 2026-03-18T12:25:16.000Z daily 0.75 https://www.medxy.ai/news/zh/recent-infections-young-adults-stroke 2026-03-18T12:25:08.000Z daily 0.75 https://www.medxy.ai/news/mechanotransduction-hepatopathy 2026-03-18T12:24:52.000Z daily 0.75 https://www.medxy.ai/news/vi/mechanical-transformation-liver-disease 2026-03-18T12:24:57.000Z daily 0.75 https://www.medxy.ai/news/ja/hepatic-congestion-response 2026-03-18T12:24:46.000Z daily 0.75 https://www.medxy.ai/news/zh/mechanotransduction-in-hepatic-disease 2026-03-18T12:24:41.000Z daily 0.75 https://www.medxy.ai/news/mapping-escape-her2-gastric-cancer 2026-03-18T12:24:22.000Z daily 0.75 https://www.medxy.ai/news/vi/map-escape-her2-cancer 2026-03-20T19:06:52.000Z daily 0.75 https://www.medxy.ai/news/ja/escaping-mapping-her2-cancer-resistance 2026-03-20T19:06:46.000Z daily 0.75 https://www.medxy.ai/news/zh/escape-map-her2-gastric-cancer 2026-03-20T19:06:39.000Z daily 0.75 https://www.medxy.ai/news/telemedicine-nutritional-therapy-liver-disease 2026-03-18T12:34:55.000Z daily 0.75 https://www.medxy.ai/news/vi/nutrition-care-telemedicine 2026-03-20T19:06:25.000Z daily 0.75 https://www.medxy.ai/news/ja/remote-nutrition-therapy 2026-03-20T19:06:19.000Z daily 0.75 https://www.medxy.ai/news/zh/remote-nutrition-therapy-2 2026-03-20T19:06:11.000Z daily 0.75 https://www.medxy.ai/news/postpartum-diabetes-screening 2026-03-20T19:05:51.000Z daily 0.75 https://www.medxy.ai/news/vi/diabetes-screening-optimization 2026-03-20T19:05:44.000Z daily 0.75 https://www.medxy.ai/news/ja/maximizing-postpartum-diabetes-screening 2026-03-20T19:05:34.000Z daily 0.75 https://www.medxy.ai/news/zh/optimized-gestational-diabetes-screening 2026-03-20T19:05:25.000Z daily 0.75 https://www.medxy.ai/news/umbilical-artery-doppler-risk 2026-03-18T12:59:44.000Z daily 0.75 https://www.medxy.ai/news/vi/doppler-decline-fetal-risk 2026-03-20T19:05:11.000Z daily 0.75 https://www.medxy.ai/news/ja/countdown-mapping-fetal-risk 2026-03-20T19:05:05.000Z daily 0.75 https://www.medxy.ai/news/zh/countdown-mapping-fetal-risk-2 2026-03-20T19:04:57.000Z daily 0.75 https://www.medxy.ai/news/return-of-value-biobanking 2026-03-18T14:02:24.000Z daily 0.75 https://www.medxy.ai/news/vi/value-return-priorities 2026-03-20T19:04:48.000Z daily 0.75 https://www.medxy.ai/news/ja/value-prioritization-black-women-endometrial-cancer 2026-03-20T19:04:42.000Z daily 0.75 https://www.medxy.ai/news/zh/prioritizing-value 2026-03-20T19:04:32.000Z daily 0.75 https://www.medxy.ai/news/bottom-up-revolution-rectal-cancer 2026-03-18T16:58:25.000Z daily 0.75 https://www.medxy.ai/news/medicaid-expansion-pancreatic-cancer 2026-03-20T19:04:21.000Z daily 0.75 https://www.medxy.ai/news/vi/medicaid-impact-on-pancreatic-cancer-survival 2026-03-20T19:04:15.000Z daily 0.75 https://www.medxy.ai/news/ja/medicaid-expansion-impacts 2026-03-20T19:04:11.000Z daily 0.75 https://www.medxy.ai/news/zh/medicaid-expansion-pancreatic-cancer-2 2026-03-20T19:04:05.000Z daily 0.75 https://www.medxy.ai/news/minimally-invasive-surgery-hospital-charges 2026-03-18T19:55:13.000Z daily 0.75 https://www.medxy.ai/news/vi/minimally-invasive-surgery-costs 2026-03-20T19:03:56.000Z daily 0.75 https://www.medxy.ai/news/hepatopancreatic-surgery-analysis 2026-03-20T19:03:51.000Z daily 0.75 https://www.medxy.ai/news/vi/economic-analysis-robotic-surgery 2026-03-20T19:03:42.000Z daily 0.75 https://www.medxy.ai/news/ja/robotic-vs-laparoscopic-surgery 2026-03-20T19:03:37.000Z daily 0.75 https://www.medxy.ai/news/zh/robotic-vs-laparoscopic-vs-open-surgery 2026-03-20T19:03:31.000Z daily 0.75 https://www.medxy.ai/news/head-neck-metastases-infraclavicular-tumors 2026-03-18T20:31:19.000Z daily 0.75 https://www.medxy.ai/news/sentinel-biopsy-merkel-cancer 2026-03-18T20:35:13.000Z daily 0.75 https://www.medxy.ai/news/vi/merkel-cell-carcinoma-sampling-issues 2026-03-20T19:03:18.000Z daily 0.75 https://www.medxy.ai/news/ja/sentinel-lymph-node-biopsy-2 2026-03-20T19:03:12.000Z daily 0.75 https://www.medxy.ai/news/zh/merkel-cell-cancer-biopsy 2026-03-20T19:03:06.000Z daily 0.75 https://www.medxy.ai/news/ophthalmic-scarcity-analysis 2026-03-20T19:02:50.000Z daily 0.75 https://www.medxy.ai/news/vi/perseverance-of-ophthalmology-shortage 2026-03-20T19:02:42.000Z daily 0.75 https://www.medxy.ai/news/ja/sustained-drug-shortage 2026-03-20T19:02:35.000Z daily 0.75 https://www.medxy.ai/news/zh/eye-drug-shortage-us-analysis 2026-03-20T19:02:27.000Z daily 0.75 https://www.medxy.ai/news/refining-surveillance-retinoblastoma 2026-03-20T19:02:10.000Z daily 0.75 https://www.medxy.ai/news/vi/rb1-genetics-macular-monitoring 2026-03-20T19:02:05.000Z daily 0.75 https://www.medxy.ai/news/ja/improving-retinoblastoma-monitoring 2026-03-20T19:01:55.000Z daily 0.75 https://www.medxy.ai/news/zh/unilateral-retinoblastoma-monitoring 2026-03-20T19:01:49.000Z daily 0.75 https://www.medxy.ai/news/lisa-mrs-iol-calculation 2026-03-19T07:10:27.000Z daily 0.75 https://www.medxy.ai/news/vi/lisa-mrs-iol-calculation-3 2026-03-20T19:01:38.000Z daily 0.75 https://www.medxy.ai/news/ja/lisa-mrs-formula-high-myopia 2026-03-20T19:01:25.000Z daily 0.75 https://www.medxy.ai/news/zh/lisa-mrs-iol-calculation-2 2026-03-20T19:01:15.000Z daily 0.75 https://www.medxy.ai/news/long-term-pneumonia-prognosis 2026-03-19T07:54:03.000Z daily 0.75 https://www.medxy.ai/news/vi/survival-prediction-cap 2026-03-20T19:01:05.000Z daily 0.75 https://www.medxy.ai/news/ja/survival-prediction-after-discharge 2026-03-20T19:00:52.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-pneumonia-survival-predictor 2026-03-20T19:00:45.000Z daily 0.75 https://www.medxy.ai/news/human-cost-respiratory-care 2026-03-19T08:11:46.000Z daily 0.75 https://www.medxy.ai/news/vi/human-cost-of-respiratory-care 2026-03-20T19:00:28.000Z daily 0.75 https://www.medxy.ai/news/ja/breathing-care-costs 2026-03-20T19:00:18.000Z daily 0.75 https://www.medxy.ai/news/zh/breath-care-labor-costs 2026-03-20T19:00:01.000Z daily 0.75 https://www.medxy.ai/news/precision-t-cell-engineering 2026-03-20T18:59:51.000Z daily 0.75 https://www.medxy.ai/news/vi/t-cell-tech-revolution 2026-03-20T18:59:46.000Z daily 0.75 https://www.medxy.ai/news/ja/allohsct-t-cell-engineering 2026-03-20T18:59:39.000Z daily 0.75 https://www.medxy.ai/news/zh/precision-t-cells-in-transplants 2026-03-20T18:59:31.000Z daily 0.75 https://www.medxy.ai/news/improving-cmml-survival 2026-03-20T18:59:27.000Z daily 0.75 https://www.medxy.ai/news/vi/cmml-survival-improvement 2026-03-20T18:59:15.000Z daily 0.75 https://www.medxy.ai/news/ja/prognosis-in-cmml 2026-03-20T18:59:03.000Z daily 0.75 https://www.medxy.ai/news/zh/improving-cmml-survival-2 2026-03-20T18:58:57.000Z daily 0.75 https://www.medxy.ai/news/ph-plus-hyperleukocytosis-all-relapse 2026-03-19T12:56:46.000Z daily 0.75 https://www.medxy.ai/news/vi/ph-plus-hyperleukocytosis 2026-03-20T18:58:41.000Z daily 0.75 https://www.medxy.ai/news/ja/ph-plus-cns-relapse 2026-03-20T18:58:36.000Z daily 0.75 https://www.medxy.ai/news/zh/ph-plus-status-cns-relapse-risk 2026-03-20T18:58:27.000Z daily 0.75 https://www.medxy.ai/news/glp1-gip-agonists-endoscopy 2026-03-19T21:01:38.000Z daily 0.75 https://www.medxy.ai/news/vi/glp1-gip-agonists-endoscopy-2 2026-03-20T18:58:18.000Z daily 0.75 https://www.medxy.ai/news/ja/glp-1-gip-agonist-discontinuation 2026-03-20T18:58:12.000Z daily 0.75 https://www.medxy.ai/news/zh/glp1-gip-agents-discontinuation 2026-03-20T18:57:47.000Z daily 0.75 https://www.medxy.ai/news/post-pandemic-firearm-acquisition 2026-03-19T21:25:19.000Z daily 0.75 https://www.medxy.ai/news/accelerated-md-graduates-performance 2026-03-19T21:49:09.000Z daily 0.75 https://www.medxy.ai/news/vi/md-program-graduates-performance 2026-03-20T18:57:31.000Z daily 0.75 https://www.medxy.ai/news/ja/md-program-graduates-performance-2 2026-03-20T18:57:36.000Z daily 0.75 https://www.medxy.ai/news/zh/md-graduates-performance 2026-03-20T18:57:39.000Z daily 0.75 https://www.medxy.ai/news/telemedicine-care-transitions 2026-03-20T18:56:55.000Z daily 0.75 https://www.medxy.ai/news/vi/remote-health-services 2026-03-20T18:56:34.000Z daily 0.75 https://www.medxy.ai/news/ja/remote-care-tools 2026-03-20T18:56:24.000Z daily 0.75 https://www.medxy.ai/news/zh/remote-healthcare-strategy 2026-03-20T18:56:13.000Z daily 0.75 https://www.medxy.ai/news/rethinking-shock-management 2026-03-19T22:54:49.000Z daily 0.75 https://www.medxy.ai/news/zh/rethinking-shock-management-2 2026-03-20T18:56:05.000Z daily 0.75 https://www.medxy.ai/news/vi/rethink-shock-management 2026-03-20T18:55:55.000Z daily 0.75 https://www.medxy.ai/news/ja/shock-management-rethink 2026-03-20T18:55:50.000Z daily 0.75 https://www.medxy.ai/news/memantine-pac-phase-2-trial 2026-03-20T09:15:10.000Z daily 0.75 https://www.medxy.ai/news/ethnic-minority-heart-failure-care 2026-03-20T09:22:26.000Z daily 0.75 https://www.medxy.ai/news/vi/high-survival-heart-failure-minorities 2026-03-20T18:55:30.000Z daily 0.75 https://www.medxy.ai/news/ja/england-heart-failure-survival 2026-03-20T18:55:39.000Z daily 0.75 https://www.medxy.ai/news/zh/higher-survival-rate-minority-patients 2026-03-20T18:55:06.000Z daily 0.75 https://www.medxy.ai/news/mechanical-heart-valves-pregnancy 2026-03-20T09:31:58.000Z daily 0.75 https://www.medxy.ai/news/vi/mechanical-valves-pregnancy 2026-03-20T15:44:16.000Z daily 0.75 https://www.medxy.ai/news/ja/mechanical-mitral-valve-pregnancy 2026-03-20T15:44:06.000Z daily 0.75 https://www.medxy.ai/news/zh/pregnancy-heart-valves 2026-03-20T15:43:54.000Z daily 0.75 https://www.medxy.ai/news/semaglutide-cost-benefit 2026-03-20T09:39:12.000Z daily 0.75 https://www.medxy.ai/news/vi/semaglutide-cost-effectiveness 2026-03-20T15:43:28.000Z daily 0.75 https://www.medxy.ai/news/ja/semaglutide-value-evaluation 2026-03-20T15:43:17.000Z daily 0.75 https://www.medxy.ai/news/zh/semaglutide-value-assessment 2026-03-20T15:43:10.000Z daily 0.75 https://www.medxy.ai/news/rethinking-mitral-regurgitation 2026-03-20T09:57:24.000Z daily 0.75 https://www.medxy.ai/news/vi/review-of-two-leaf-valve 2026-03-20T15:43:03.000Z daily 0.75 https://www.medxy.ai/news/ja/revisiting-mitral-regurgitation-hcm 2026-03-20T15:42:59.000Z daily 0.75 https://www.medxy.ai/news/zh/revisiting-mitral-regurgitation 2026-03-20T15:42:50.000Z daily 0.75 https://www.medxy.ai/news/afternoon-evening-exercise 2026-03-20T10:11:48.000Z daily 0.75 https://www.medxy.ai/news/vi/optimize-workout-timing 2026-03-20T15:42:43.000Z daily 0.75 https://www.medxy.ai/news/long-term-survival-nasopharyngeal-carcinoma 2026-03-20T15:42:29.000Z daily 0.75 https://www.medxy.ai/news/precision-nutrition-oncology-analgesia 2026-03-20T15:42:37.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-survival-head-neck-cancer 2026-03-20T15:42:02.000Z daily 0.75 https://www.medxy.ai/news/vi/precision-nutrition-cancer-care 2026-03-20T15:41:53.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-survival-nasopharyngeal-cancer 2026-03-20T15:41:29.000Z daily 0.75 https://www.medxy.ai/news/ja/precision-nutrition-clinical-milestones 2026-03-20T15:41:14.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-survival-nasopharyngeal-cancer-2 2026-03-20T15:41:05.000Z daily 0.75 https://www.medxy.ai/news/natural-history-acute-eosinophilic-myocarditis 2026-03-20T15:40:55.000Z daily 0.75 https://www.medxy.ai/news/zh/precision-nutrition-oncology-2025 2026-03-20T15:40:41.000Z daily 0.75 https://www.medxy.ai/news/african-representation-trials 2026-03-20T15:40:33.000Z daily 0.75 https://www.medxy.ai/news/vi/africa-global-representation 2026-03-20T15:40:06.000Z daily 0.75 https://www.medxy.ai/news/ja/filling-evidence-gaps-africa 2026-03-20T15:39:57.000Z daily 0.75 https://www.medxy.ai/news/zh/bridging-evidence-gap 2026-03-20T15:39:50.000Z daily 0.75 https://www.medxy.ai/news/precision-medicine-dilated-cardiomyopathy 2026-03-20T15:39:41.000Z daily 0.75 https://www.medxy.ai/news/vi/precision-medicine-cardiomyopathy 2026-03-20T15:39:35.000Z daily 0.75 https://www.medxy.ai/news/ja/expanded-cardiomyopathy-genetic-counseling 2026-03-20T15:39:23.000Z daily 0.75 https://www.medxy.ai/news/zh/precision-medicine-cardiomyopathy-2 2026-03-20T15:39:16.000Z daily 0.75 https://www.medxy.ai/news/patient-engagement-home-blood-pressure-monitoring 2026-03-20T13:56:16.000Z daily 0.75 https://www.medxy.ai/news/redefining-risk-diabetes 2026-03-20T15:39:07.000Z daily 0.75 https://www.medxy.ai/news/vi/diabetes-kidney-risk-classification 2026-03-20T15:39:01.000Z daily 0.75 https://www.medxy.ai/news/ja/diabetes-kidney-disease-risk 2026-03-20T15:38:56.000Z daily 0.75 https://www.medxy.ai/news/zh/redesigning-diabetic-nephropathy-risk 2026-03-20T15:38:50.000Z daily 0.75 https://www.medxy.ai/news/insulin-resistance-lung-function 2026-03-20T14:08:08.000Z daily 0.75 https://www.medxy.ai/news/vi/insulin-resistance-and-hyperinsulinemia 2026-03-20T15:38:44.000Z daily 0.75 https://www.medxy.ai/news/zh/insulin-resistance-diabetes-2 2026-03-20T15:38:27.000Z daily 0.75 https://www.medxy.ai/news/metformin-blunts-exercise-benefits 2026-03-20T15:38:34.000Z daily 0.75 https://www.medxy.ai/news/polygenic-risk-scores-gck-mody 2026-03-20T14:16:29.000Z daily 0.75 https://www.medxy.ai/news/levothyroxine-ageing-patient 2026-03-20T19:07:45.000Z daily 0.75 https://www.medxy.ai/news/vi/levothyroxine-elderly-cardiovascular-evaluation 2026-03-20T19:07:50.000Z daily 0.75 https://www.medxy.ai/news/ja/levothyroxine-cardiovascular-outcomes 2026-03-20T19:08:02.000Z daily 0.75 https://www.medxy.ai/news/long-term-air-pollution-mnd 2026-03-20T19:08:11.000Z daily 0.75 https://www.medxy.ai/news/zh/levothyroxine-elderly-patients 2026-03-20T19:08:24.000Z daily 0.75 https://www.medxy.ai/news/sbp-trajectories-recovery 2026-03-20T16:15:50.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-goals-hypertension-recovery-prediction 2026-03-20T19:08:29.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-goals-blood-pressure-recovery 2026-03-20T19:08:35.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-targets-hemorrhage-recovery 2026-03-20T19:08:41.000Z daily 0.75 https://www.medxy.ai/news/amygdala-social-cognition 2026-03-20T19:09:01.000Z daily 0.75 https://www.medxy.ai/news/vi/anterior-insula-role-empathy 2026-03-20T19:09:07.000Z daily 0.75 https://www.medxy.ai/news/zh/rethinking-amygdala-role 2026-03-20T19:09:23.000Z daily 0.75 https://www.medxy.ai/news/functional-network-mapping-cerebral-palsy 2026-03-20T18:54:35.000Z daily 0.75 https://www.medxy.ai/news/vi/motor-cortex-network-infant-stroke 2026-03-20T19:09:30.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-motor-cortex-2 2026-03-20T19:09:38.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-motor-cortex 2026-03-20T19:09:46.000Z daily 0.75 https://www.medxy.ai/news/intestinal-ultrasound-ulcerative-colitis 2026-03-20T19:10:15.000Z daily 0.75 https://www.medxy.ai/news/dietary-lipid-sequestration-colorectal-cancer 2026-03-22T20:33:06.000Z daily 0.75 https://www.medxy.ai/news/vi/fat-capture-colon-cancer 2026-03-22T20:33:00.000Z daily 0.75 https://www.medxy.ai/news/ja/dietary-lipids-colon-cancer 2026-03-22T20:32:53.000Z daily 0.75 https://www.medxy.ai/news/zh/dietary-lipid-metabolism-colon-cancer 2026-03-22T20:32:45.000Z daily 0.75 https://www.medxy.ai/news/iron-deficiency-pregnancy 2026-03-22T20:32:37.000Z daily 0.75 https://www.medxy.ai/news/vi/iron-deficiency-management-pregnancy 2026-03-22T20:32:31.000Z daily 0.75 https://www.medxy.ai/news/ja/iron-deficiency-management-pregnancy-2 2026-03-22T20:32:27.000Z daily 0.75 https://www.medxy.ai/news/zh/optimal-iron-deficiency-management 2026-03-22T20:32:19.000Z daily 0.75 https://www.medxy.ai/news/beyond-pink-ribbon 2026-03-22T20:32:09.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-pink-ribbon-analysis 2026-03-22T20:32:02.000Z daily 0.75 https://www.medxy.ai/news/ja/pink-ribbon-funding-gap 2026-03-22T20:31:56.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-pink-ribbon-analysis 2026-03-22T20:31:46.000Z daily 0.75 https://www.medxy.ai/news/endometriosis-care-challenges 2026-03-22T20:31:39.000Z daily 0.75 https://www.medxy.ai/news/vi/coping-with-endometriosis-crisis 2026-03-22T20:31:32.000Z daily 0.75 https://www.medxy.ai/news/ja/invisible-crisis-endometriosis-care 2026-03-22T20:31:26.000Z daily 0.75 https://www.medxy.ai/news/zh/coping-with-endometriosis 2026-03-22T20:30:47.000Z daily 0.75 https://www.medxy.ai/news/stratifying-splenomegaly-risk 2026-03-22T20:30:41.000Z daily 0.75 https://www.medxy.ai/news/vi/risk-classification-lach-to 2026-03-22T20:30:35.000Z daily 0.75 https://www.medxy.ai/news/ja/risk-stratification-splenomegaly 2026-03-22T20:30:31.000Z daily 0.75 https://www.medxy.ai/news/zh/risk-stratification-splenomegaly-2 2026-03-22T20:30:23.000Z daily 0.75 https://www.medxy.ai/news/lymph-node-dissection-lung-adenocarcinoma 2026-03-21T12:31:17.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-common-standards 2026-03-22T20:30:10.000Z daily 0.75 https://www.medxy.ai/news/ja/lymph-node-dissection-value 2026-03-22T20:30:04.000Z daily 0.75 https://www.medxy.ai/news/mitochondrial-resilience-annexin-a2 2026-03-21T14:03:00.000Z daily 0.75 https://www.medxy.ai/news/vi/endurance-of-annexin-a2 2026-03-22T20:29:50.000Z daily 0.75 https://www.medxy.ai/news/ja/mitochondrial-elasticity-explained 2026-03-22T20:29:55.000Z daily 0.75 https://www.medxy.ai/news/zh/unlock-mitochondrial-resilience 2026-03-22T20:29:46.000Z daily 0.75